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SOMMAIRE
L’idée de cette recherche est inspirée par les interactions entre espèces
chargées dans la nature. Les molécules d’ADN ainsi que ta surface des cellules
sont normalement chargées négativement et par conséquent des polymères
cationiques ont le potentiel d’interagir avec celles-ci. Des interactions de ce genre
ont déjà été étudiées pour des applications bio-médicales, incluant le relargage de
médicaments, la thérapie génique, et en génie tissulaire. Les polymères contenant
des composants endogènes tels que les acides biliaires, peuvent être utilisés pour
ce genre d’applications.
Cette étude se concentre sctr la synthèse de polymères chargés
positivement, dérivés de l’acide cholique (un des acides biliaires). [(2’-Diméthyl
amino)éthylène]-3a-methacryloyl-7ci, l2Œ-dihydroxy-5 f3-cholanoaminde (mo
nomère A) et [(2 ‘-tert-butyloxycarboxamido )éthylnèj-3 a-methaciyloyl-7a, Ï 2a-
dihydroxy-5f3-cholanoamide (monomère B), ont été synthétisés et serviront pour
préparer des polymères cationiqLles. Cependant comme de nombreux problèmes
de synthèse ont été rencontrés avec le monomère A, seulement monomère B a été
utilisé. Des homopolymères et copolymères ont été synthétisés par polymérisation
radicalaire. L’homopolymère est sensible au pH et a été copolymérisé avec le N
isopropylaciylamide qcti est connu pour générer des polymères thermosensibles.
Les différents ratios de ces deux composants (monomère B et le N
isopropylacrylamide) affectent la sensibilité au pi-I et à la température. Les
propriétés physiques et chimiques de tous les homopolymères et copolymères ont
été caractérisées par les techniques physico-chimiques telles que la
chromatographie d’ exclusion stérique, la spectroscopie de résonance nucléaire
magnétique, la spectroscopie infra-rouge à transformée de Fourier, la
spectrométrie de masse, l’analyse élémentaire, le titrage potentiométrique,
l’analyse thermogravimétrique, et la spectrophotometrie UV-visible.
Mots clés : acide cholique; vecteur non-viral; charge positive; polymère
thermosensible; polymère sensible au pH
ABSTRACT
The idea of this research stems from interactions observed between
charged species in nature. DNA molecules and the surfaces of celis are normally
negatively charged. Positively charged polymers can potentially interact with ceils
and DNA molecules, and have been considered for bio-medical applications
including drug deÏivery, gene therapy and tissue scaffolds. Polymers containing
endogenous compounds such as bile acids may be used for such applications.
The focus of this study relates to the synthesis of positively charged
polymers derived from cholic acid ta bile acid). [(2’ -Dimethylamino)ethylene]
3 a-methacryloyl-7a, I 2a-dihydroxy-5 f3-cholanoamide (monomer A) and [(2’ -tert
butyloxycarboxamido)ethylene]-3 a-methacryloyl-7a, l2Œ-dihydroxy-5 f3- chol
anoamide (monomer B) were synthesized from cholic acid and served as
monomers for preparing cationic polymers. However, because there are lots of
synthetic problems with monomer A, only monomer B was used for
polymerization. Homopolymers and copolymers were synthesized from monomer
B by free radical polymerization. The homopolymer displayed pH sensitivity.
Monomer B derived from cholic acid was copolymerized with N
isopropylacrylaminde, which is known to generate thermosensitive polymers. The
different ratios ofthese two components affect the thermo- and pH-sensitivities of
the copolymers. The chemical and physical properties of ail the homopolymers
and copolymers were characterized by the use of various physical-chemical
techniques such as size exclusion chromatography, nuclear magnetic resonance,
Fourier transform infrared spectroscopy, mass spectrometry, elernental analysis,
potentiometric titrati on, thermogravimetry and UV-visibl e spectrophotometry.
Keywords: cholic acid; non-viral vector; positive charge; thernio sensitive
polymer; pH sensitive polymer;
II
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In vivo, an overail net positive charge of the lipoplexes helps to associate the
complex with the negatively charged ceil membrane. Entiy of the lipoplexes into
the ce!! may occur by the process of endocytosis via the lipid moieties of the
liposome. 23 Following cellular intetnalization, the complexes appear in the
endosomes and later in the nucleus.
(2) Cationic polyrners
In general, the structures of cationic polymers (polycations) for non-viral
vectors are divided into two parts: cationic branched polymer and hydrophilic linear
polymers with ligands. Cationic polymers (i.e., proton-sponge polymers) can easily
complex with anionic DNA molecules. The complexes formed between DNA and
cationic polymers are called polyplexes as shown in figure 1 .4.
-b -b
cPCP-Biotin
DNA
q...
6”’
DNA
q..
6’
II
NeutrAvidin Surface
Figure 1.4 Schematic of the substrate-mediated delivery strategy, CP
represents the cationic polymer used for condensation.26
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Polyplexes are commonly used as non-viral vectors.24 The general mechanisrn
of action of polyplexes is based on the generation of positively charged complexes
which can interact with the negatively charged celi surface. When cationic
polymers are mixed with DNA, they readily self-assemble together. The cationic
bral1ched polymers trap DNAs by electrostatic interaction, and then the complex is
sctrrounded by a hydrophilic linear polymer which may possess a terminal ligand
(such as biotin). The result is the formation of small toroidal or spherical structures.
When polypiexes are added to ceils in culture, the polyplexes are taken up by the
cells after the ligand is detected by the targeting ccli. These complexes often take
advantage of the pH change in the endosome to trigger an endosomal rupture and
improve DNA uptake.25 Similar to that of cationic lipids, transfection activity of
cationic polymers varies witb ccli type, structure, size of the polymer, and polymer
to DNA ratio.26
Compared to cationic lipids, the major drawback of cationic polymers is their
relatively high toxicity. Also, the transfection efficiency of these systems is often
below effective levels.25 The properties of cationic polymers can be easily
controlled to improve biocompatibility (toxicity or immunogenicity),
biodegradability, and efficiency. The design of new polymer materials bas turned
out to be one of the most promising strategies foi- developing gene delivery vectors
with improved properties.
Non-viral gene deliveiy is typicafly much safer but suffers from generafly
unsatisfactory delivery efficiency. The earliest synthetic vehicles reported in the
literature were not originally designed for gene delivery (i.e. poly(L-lysine) (PLL)
and poly(ethyleneimine) (PEI)).2728 The gene delivery efficacy of such materials is
haphazard and typically insufficient foi- clinical application. In recent years, a
variety of polymers have been designed specifically for gene delivery. Based on the
large number of studies of these basic polymers, investigators learned a lot about
the stntcture—function relationships existing for polymer vectors. With growing
understanding ofpolymer gene delivery mechanisms it is likely that polymer-based
gene delivery systems will become an important tool for human gene therapy.
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1.3 Current research in cationic polymers
Cationic polymers are polymers that contain positively-charged groups
covalently linked to the polymer molecule, such as phosphonium, suiphonium, and
ammonium cations. They are used in different territories such as cosmetic and drug
7930delivery. -
In cosmetics, the cationic polymer changes its behaviour when surfactants are
included in the formulation. Because anionic surfactants bind to cationic polymers,
they form a complex phase known as coacervate. Therefore, the polymer can
deposit onto the anionic surface of hair and skin.3’ For instance, cationic polymer
complexes formed between polymers like polyquateniium-6 and retinoic acid
(Vitamin D) are a powerful skin exfoliating agent and help to stabilize the labile
vitamin by prolonging its chemical life and potentially increasing its potency.3
However, cationic polymers and their complexes are neither water-soluble nor
dispersible in water, and have found less practical applications in personal care.
In drug ddllvery, cationic polymers contain pendant basic groups (e.g. amines
or ammonium saïts) which either accept or release protons in response to changes in
the environmental pH. Figure 1 .5 shows a generalized structure of a cationic
polyelectrolyte and its pH-dependent ionization. These characteristics are used for
drug release and drug delivery, and also foi- their activity against a number of
bacteria and fungi. u The positively charged sites are able to form polymeric
cationic bridges in specific sites in the body including ccli surfaces or neutralization
of the negative charges of DNA. Such ionization causes cationic polyelectrolytes to
exhibit greater solubility in aqueous solution at low pHs, or if cross-linked, to swell
to a greater extent. These great qualities have been studied for gene therapy (for
non-viral vectors) and drug applications (drug release).34’3 The following sections
will describe in further details ofthose applications.
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CH2CH2NH(CH2CH3)2 CH2CH2N(CH2CH3)2
Figure 1.5 pH-dependent ionization of polyelectrolytes
1.3.1 Cationic polymei in gene therapy
Cationic polymers have been widely studied. They seem to be the most
promising vebicle for gene therapy. Seif-assembling complexes ofnucleic acids and
synthetic cationic polymers are formed as the resuit of electrostatic interactions
between the negatively charged phosphate groups of the DNA and the positively
charged groups of the polycations. Wide arrays of polycations are available for the
studies of gene therapy and include those with linear, branched, dendritic and block
or graft copolymer architectures. These polycations vary greatly in chemical
composition as welI as the number of repeating units, providing for a wide range of
different polyplexes that can be easily assembled. Much ofthe research ofpolymer
based gene delivery indicates that polycations serve as potential reagents in the
fie Id.
The major mechanism of gene deiivery for this non-viral vector is endocytosis
of polyplexes (DNAs, cationic polymers), followed by disruption of the endosomal
membrane as shown in figure 1 .6. However, in general, cationic polymers alone do
not appear to be ideal candidates for bio-adhesion to celi surfaces because of
toxicity. Some of the studies have indicated that cationic polymers tend to cause
openings or holes in the ccli membrane22’ 36 possibly due to neutralization of
negative charges on the celi surface and formation of polymeric cationic bridges
which crosslink opposite membrane surfaces. 22 Cationic polymers are inherently
toxic to animal species because oftheir destructive interaction with ceIl membranes.
The toxicity of such polymers is related to the charge density of the cationic
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polymer.37 By modifying the cationic polymer structures, these shortcomings have
been improved in many studies.34’38 Polycations have been modified with a number
of groups and modalities, including chemical groups for shielding of the cationic
charge, targeting groups for specific celis, and biodegradable linkers for increased
biocompatibility.
DNA complexation 1
ofDNA
&
Figure 1.6 Schematic generalized representation of the delivery of a DNA
based therapeutic using a non-viral vector (cationic polymers) (this figure
is post on http://www. nano-lifescience. com/research/genedelivery. html): (1)
Cationic polymers which promote particle (complexation) act as a scaffold
for DNA condensation and coupling of bioactive ligands (binding with a
high specificity and affinity to the recognition sites). (2) The complexation
binding to the celi surface. (3) The complexation crosses the plasma
membrane. (4) DNA escapes form the endosome into the cytoplasm. (5)
Transport the DNA into the nucleus.
A!though the safety of the cationic polymers (in oncogenicity and
immunogenicity) as non-viral vectors has been established in many studies,39’4°
non-viral vectors have much lower transfection efficiency than viral vectors. The
presence of positive charges at the surface of polyplexes can promote unwanted
non-specific interactions with serum proteins and ce!! membranes.4’ Therefore, in
vitro (without plasma issue), the efficiency of polyplexes is good, but in vivo, it is
poIyition
with hgand
bindnq to the
receptor
2
endocytosîs
3
4
nucleus
nuclear traffickin9
—z
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CHAPTER 1
INTRODUCTION
1.1 Background
One of the most promising areas of therapeutic research is gene therapy.
Therapeutic genes are ctsed to “reprogram” ceils into producing their own
therapeutic agents and tum off unwanted or detrimentai cell growth or activity.
Many diseases are due to cellular processes which do flot function properiy at the
molecular level. These cellular processes are regulated by proteins which are
synthesized in the ccli according to the genetic information stored in DNA. By
adding external DNA or RNA into the ceils to induce or suppress a specific
function, gene therapy can be used to combat a wide range ofdiseases.
1.2 Vectors for gene therapy
- Concept
Gene therapy faces numerous challenges, most notably getting the genes to,
and then into, the targeted ceils in the body. Currentiy, there are two main
approaches: viral and non-viral vectors.
Viral and non-viral vectors have been widely studied for the past decade. Viral
vectors include retroviruses, adenoviruses, and adeno-associated viruses. Non-viral
vectors include cationic lipids/iiposomes, and cationic poiymers. The fundamental
principles by which these vectors access the target ccli are simiiar: the ceiis uptake
the therapeutic gene carriers, transfect, and then replace the defective gene (Figure
I . i). However, the propetties of such systems differ greatly.
DNA D&ivery Vector
DMA-based f
Therapeutc I
Figure 1.1 Generalized representation of the delivery of a DNA-based
therapeutic using a viral or non-viral DNA delivery vector: (1)
complexation and/or entrapment of DNA-based therapeutic with DNA
delivery vector; (2) interaction of DNA-based therapeutic-vector
complex with ceil membrane; (3) cellular intemalization via receptor- or
non-receptor-mediated endocytotic pathways; (4) endosomal breakdown;
(5) cytoplasmic release of DNA-based therapeutic-vector complex or
DNA-based therapeutic alone; (6) dissociation of DNA-based therapeutic
from vector; (7) nuclear translocation of viral vectors or DNA-based
therapeutics.’
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1.2.1 Viral Vectots
Viruses are very efficient for transfecting into ceils and producing new viral
particles. A foreign gene can be placed into a virus, and these recombinant viral
vectors are then used to enter the host ccli. The main idea of gene therapy using
viral vectors is that vectors infect the ccli and change the cell’s defective genes with
the new substituted ones. Viral vectors can be sub-divided into three categories: 2
Retroviruses are a large family of RNA viruses which inciude spumavirus
(foamy viruses), lentivirus and moloney-murine-ientivirus-related viruses. The
diameter oft-etroviral virions range from 80 to 130 nm, and their genomes consist of
two identically positive-sense single-stranded RNA molecules. The genomes are
encased inside a capsid (enveiop) aiong with the integrase and reverse transcriptase
enzymes. Retroviral vectors are capable of transfecting high populations of primaly
human endothelial and smooth muscle cells, a class of cells that is generaliy
extremely difficult to transfect.3 Retroviral vectors are the most widely used virai
vectors in clinical trials at present. The most important advantages of retroviral
vectors are their ability to transform and stably integrate into the target cefl genome.
However, they have been demonstrated to lose long-term expression capabiiity
which limits their potential for clinical application. Furthermore, they are
extremely difficuit to produce on a iarge-scaie because they are inherently unstable.
Adenoviruses are non-enveioped, icosahedral, doubie-stranded DNA viruses
with a capsid diameter of 70—100 nm, and comprised of 252 capsomeres (240
hexons and 12 pentons). They are not incorporated into the genome of the target
ccli (non-integrating), but remain as an extrachromosomal entity in the nucleus of
the host ccli. Consequently there is no risk of insertional mutagenesis.3 Replication—
defective recombinant adenoviruses are the second most commoniy used viral
vectors in clinical trials today. Adenovirai vectors are known to generate
inflammatory responses in tissues with short-lived gene expression. There is
concern over loss of transgenic expression upon tissue maturation when celis have
been transfected using viruses. 6 However, it has been demonstrated that
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adenoviruses in formulations may lose their potency after storage in commonly
used pharmaceutical vials.7
Adeno-associated viruses (AAV) are non-pathogenic human parvoviruses
(parvoviruses are among the smallest, simplest eukaiyotic viruses) which depend on
a helper virus, usually an adenovirus, to proliferate. Compared to the other vectors,
adeno-associated vircises (AVV) medi ate stable transgenic expression in terminally
difTerentiated celis without inducing significant inflammatory toxicity.8 Therefore,
9 10AAV’s only slightly damage the target celis. ‘ However, there is evidence to
suggest that AAVs are significantly less efficient than retroviral vectors at
transducing primary—cell cultures. Il 12 In primary—cell transductions, most of the
DNA does not integrate into the host genome but remains extrachromosomal, and
this inefficiency might limit its use for in vivo application.
Viral vectors have shown excellent transfection efficiencies. However, the
limitations restrict their clinic applications. Viral vectors can cause immune
responses, creating a number of serious safety risks such as potential oncogenicity,
toxicity and the development of high immunogenicity after repeated
administration.13”4 Fctrthermore large scale production may be difficult to achieve.
Because ofthese drawbacks, non-viral strategies are becoming more attractive.
1.2.2 Non-viral vectors
Although the number of clinical trials with viral carriers overshadows that of
non—viral catTiers due to their inherently high degree of transfection and their
increased persistence of gene expression, these carriers are prone to trigger host
immunogenic responses and are limited in the transgene size.’5 Non-viral vectors
can overcome many of the problems encountered with viral vectors. Non-viral
methods of DNA transfer require only a small number of proteins; have a virtually
infinite capacity; have little or no infectious or mutagenic capability and large scale
production is possible using pharmaceutical techniques. 16, 17 DNA with cationic
polymers are considered to be one of the most promising candidates for non-viral
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gene delivery systems.’8”9’2° Cationic polymers, a non-viral system may, in the near
future, overcome sorne of the problems inherent to currently employed viral gene
delivery systems. Current studies of non-viral vectors are focused on cationic
lipids/Iiposomes and cationic potymers.
(1) Cationic Iipids/liposomes
The preparation of liposomes requires molecules with three specific parts: a
hydrophobic anchor, a Iinker, and a beaU group (figure 1.2).21 The hydrophobie
anchor and positively charged beaU group offer the important characteristics of self
assembly in aqueous solution. The cationic head group of the lipid compound
associates with negatively charged phosphates on the nucleic acid, resulting in
compaction of the nucleic acid in a liposome/nucleic acid complex.
o CH
+1À N—CH3
b CH3
Hydrophobie Anchor Linker Head Group
Figure 1.2 The general structure ofa cationic lipid.
As shown Figure 1.3, the hydrophobie end ofthe molecule avoids contact with
water, while the positively charged head group seeks contact with water. In order to
protect their hydrophobie end from water and expose the hydrophilic end, the
molecules self-assemble into positively charged bilayers of phospholipids
structures. When DNAs are introduced into the aqueous center of the liposomes,
they are referred to as lipoplexes. Lipoplexes, a negatively charged DNA plasma in
an aqueous compailment, is centered into a micelle-type structure. Lipoplexes
mostly or totally protect the DNA from the outside environment and have a high
affinity towards cell membranes.22
significantly lower, because of the non-specific binding in the blood plasma.42’43 To
overcome these problems, the most attractive strategy is to replace non-specific
electrostatic interactions between the transfection complexes and cefls with ccli
specific interactions that trigger receptor-mediated endocytosis of the DNA
complexes. Such an active targeting requires the use of ligands such as sugar
residues, peptides, proteins and antibodies34 that bind with a high specificity and
afflnity to the recognition site (Figure 1 .6).
Cationic polymers are the frst suitable candidate of gene carriers, as stated
before. CutTently, several cationic polymers are being studied and include PLL, PEI,
chitosan and dendrimers (Figure 1 .7). Polymeric transfection systems are
advantageous in that they are safer than viral systems and are non-oncogenic.
However, each polymer used for this application bas its own specific advantages
and disadvantages.
NHH
_
NH2 H NH2
ChitosanPoly(L-Iysine)
HN
L NH
H2N NH N NH
N
Ç HN
N N N N HH 2
Branched PoIy(ethyleneirnine)
N 2
Poly(amidoamine) (Dendrimer)
figut-e 1.7 Structures ofthe commonly used cationic polymers for gene therapy
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(1) PLL
The biodegradable cationic poÏymer PLL bas been widely used as a non-viral
vector because of its excellent DNA condensation propeiies.44 PLL protects DNA
from the attack of nucleases efficiently and the polyplexes can be rapidly
internalized to the ceIl. 46 However, it has the highest toxicity among the
polycations, because the cations on its amino acid backbone interact with the cell’s
surface, and reduces the recycling capacity of selected membrane components as
well as membrane fluidity.47 Moreover, PLL-DNA complexes show a low level of
transfection since the complexes Iack of normal communication with lysosomes and
are therefore unable to be rapidly released from endosomes.46 Many copolymers
have been studied to reduce the toxicity and to enhance the transfection.44 Many
studies on copolymers with poly(ethylene glycol) (PEG) blocks bearing targeting
ligands have shown that PEG shields the surface charges of PLL and can help in the
steric stabilization due to its charge neutrality and water so1ubility.444S49 The
presence of the ligands can prevent non-specific interactions of the polymer with
cellular components.50’5’ PLL-PEG complexes with ligands-grafted micelles had
high transfection efficiencies and low cytotoxicities compared to PLL alone.34
(2) PEÏ
Today, PET is the most commonly studied non-viral gene delivery polymer.
Typically, the synthesis of PET is through acid-catalyzed, ring-opening cationic
polymerization of aziridine, resulting in (NHCH2CH2) monomer units with
branched or linear conformations. Protonation of these amines confers PEI with the
highest cationic density of all synthetic polymers for the purpose of DNA
condensation. Simultaneously, PET offers better protection against nuclease
degradation and escape from the lysosomal compartment than other polycations, e.g.
PLL, while also showing greater transfection.52’ However, a highly cationic PET
gene carrier may also attract anionic components in the blood stream such as
erythrocytes.54 Moreover, the unfavorable interactions may result in aggregation
and removaÏ from the body though the reticuloendothelial system.5 Consequently,
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there is an intricate balance for obtaining optimal cationic condensation of plasmid
DNA witbout excessive cationic charge.6
PEI architecture has two forms: branched or linear. Both have advantages and
disadvantages,7 but the majority ofPEI research reported in the litterature bas been
conducted with brancbed PET, possibiy due to its increased number of primary
amines that are widely availabie for conjugation to other modalities. In order to
control toxicity whiie maintaining high transfection, research is culTently focused
on iowering the moiecular weight of PET in combination with other moiecuies.58’
furthermore, PEI does not contain active groups for tissue or ccli targeting;
therefore, researchers have attached a number of targeting modalities such as
cholesterol and antibodies.60’6’
(3) Chitosan
Chitosan, a neutral polysaccharide having structural characteristics similar to
glycosaminoglycans, is non-toxic and biodegradable.62 It bas therefore been widely
employed in pharmaceutical and biomedical fleids.63 In recent years, biocompatible
chitosan microspheres and beads have been investigated as non-viral vectors
because positively charged chitosan can be complexed with negatively charge
DNA.64 Also, chitosan can effectiveiy bind DNA and protect it from nuciease
degradation.6 In the manufacturing process of DNA-chitosan complexes, chitosan
has many advantages during preparation and storage process. However, the levels
of gene expression are very iow, and response time is very long.66’67 Furthermore, at
high doses, chitosan causes hypercholesterolemia and therefore bas Timited
applications.68
(4) Dendrimers
Dendrimers represent a promising ciass of motecules for use as vehicies for
drug deiivery.69’70’7’ The principie advantages that dendrimers offer inciude i) a
well—defined composition, ii) multiple sites for manipulation and iii) a globular
shape offering a protected hydrophobic interior that can be empioyed to solubiiize
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guests. The most commonly used dendrimer for gene delivery is polyamidoamine
(PAAM) (Figure 1.7). PAAM can be synthesized from the core, and outspread
generation by generation with very low polydispersity. The 3-dimensional sphericai
structure oF the resulting polymer can be used for gene therapy.7273 Because of its
low polydispersity, it can lead to reproducible gene delivery and a clinically reliable
formulation.74 The capability of dendrimers to transfect ceils is dependent upon the
size, structure and number of primary amino groups on the surface of the
dendrimer. However an increased flexibiiity ofthe dendrimer with a better ability to
complex DNA may be difficuit to achieve.7
In truth, cadi platform (linear or dendritic polymer) has its advantages and
disadvantages. Efforts to understand the appropriate roles for each strategy wiil
require investigations of ail systems at ail levels. The first generation of polymer
bound therapeutics are in and emerging from clinical trials. These polymers convey
three principal advantages to the drug: (1) they increase solubility; (2) they increase
vascular circulation time; (3) they attenuate toxicity of the drug through selective
targeting as a result of ligand/receptor interactions or enhanced permeability and
retention that tumors show for large molecules. The success of these systems offers
compelling motivation and proof of concept for tic examination of the next
generation of polymer therapeutics.
1.3.2 pH sensitivity of cationic polymers in drug release
Cationic polymers were originally investigated for pH-sensitive controlled
drug delivery in oral administration before the gene delivery. pH-sensitive polymers
synthesized with either acidic or basic components demonstrate reversible
swelling/deswelling in acidic or basic media. Because of the number of ionizable
groups on its backbone, cationic polymers can respond to changes in pH (Figure
1 .5). During tic passage of the drug delivery systems from the esophagus through
the stomach to intestine, tic product is exposed to a variable pH ranging from 2-4 in
the stomach and 6-8 in tic intestines. Utilizing this physiological property, many
drugs have been developed for controlled release.
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Hydrophobicity and degree of ionization play important roles in pH-controlled
drcig systems. Traditionally, sustained delivery systems use the stomach as an area
for drugs to dissociate from their host. In the intestines, the unique environmental
conditions and the presence ofhigh concentrations ofbacteria can substantially alter
the rate of drug release for the delivery system. Hydrogels made of cross-linked
polyelectrolytes display large differences in swelling properties depending on the
pH of the environment. For polycationic hydrogels, the swelling is minimal at
neutral pi-I, thus minimizing drug release from the hydrogels. This property has
been used to prevent release of foul-tasting drugs into the neutral pH environment
of the mouth. Polycationic hydrogels would be ideal for localized deliveiy of
antibiotics in the stomach.76
1.4 Thermo sensitive polymers V
Thermo sensitive polymers are hydrogels which are a group of stimuli-
sensitive polymers that show a phase transition in response to a temperature
change.77’ They have been extensively studied in the past decade because of their
potential applications in many fields such as membranes, drug delivery systems,
80 81 $2 $3ccli culture, the isolation of bio—molecules and enzyme activity control
Many thermo sensitive polymers exhibit a lower critical solution temperature
(LCST), which is defined as the temperature of the phase transition fiom a soluble
to an insoluble state in an aqueous solution. It is presumed that the main mechanism
of such a phase transition induced by a temperature change may be a drastic change
in the hydrogen bonding between the polymer and surrounding water molecules.
These polymers have attracted interest of many investigators because of their
intelligent ability to deliver the drug they contain to the desired places under
optimal conditions. Such polymers are physically characterized by their LCST or
cloud point. The LCST of the polymers usually varies with the presence of
additives such as electrolytes, organic solvents and surfactants.
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Ihermo sensitive drug release polymers are designed to possess sensitivity
towards small changes of temperature (physiological temperatures), which leads
either to an expansion or a contraction of their structure. Such systems exhibit
dimensional changes leading to the release of their drug contents. Polymers such as
poly(N-isopropylacrylamide (PNIPAM) (shown in figure 1.8) or their copolymers
are ofien used to immobilize enzymes or as carriers of certain functional groups
important for biochemical or bio-medical applications. Ihere are many
researchers who have worked on PNIPAM which is one of the most frequently
studied temperature-responsive hydrogels. PNIPAM exhibits a remarkable
shrinkage with increasing temperature (LCST takes place around 32 °C).
Copolymerization ofNIPAM with other monomers can bring the LCST close to the
body temperature.86
tCH2ÇH+
CH3 CH3
ziT
poly(N-isopropylacrylamide (PNIPAM)
figure 1.8 The chemical structure of PNIPAM and the dehydration of
PNIPAM above its LCST
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Figure 1 .8 also shows that PNIPAM chain changes its shape at the LCST from
a random cou (left) to spherical globule (right). This phenomenon bas been reported
widely.87’88 As tbe temperature increases, inter—molecular hydrogen—bonding witb
water begins to break and the polymer changes conformation so as to favor intra
molecular hydrogen-bonding among the amide groups along its backbone. Because
the changes induced by temperature are strictly due to conformation, the response
of PNIPAM to temperature stimuli is reversible and •fast.
1-lydrogels wbich are responsive to botb temperature and pH can be made by
simply incorporating ionizable and hydrophobic (inverse thermo sensitive)
ftinctional groups to the same hydrogels. When a small amount of cationic
monomers bearing cationic groups (such as amine) is incorporated into a thermo
sensitive polymei-, its LCST becomes dependent on tbe pH due to their ionization
prope1ies. As the pH of the medium decreases below the pK1 of the amine groups,
the LCST sbifts to bigher temperatures due to the increased bydrophilicity and
charge repulsion. These copolymers could be customized to be doubly sensitive to
external temperature and pH stimuli.
1.5 Backgtound on bile acids and their polymers
Bile acids are natural compounds which are in the family of steroids.
Synthesized in the liver, they are generally conjugated witb glycine and taurine
(e.g., glycocholic and taurocholic acids). Different groups on positions 7 and 12
define different types of bile acids (shown in Figure 1.9). The bile acids in the salt
form are detergent-like substances secreted from the gallbladder and aid in the
digestion and absorption of lipids. Like a detergent, bile acids contain hydrophobie
and hydrophilic components. Because of their idiosyncratic structures, bile acids
have facial amphiphilicity whicb causes them to form micelles and supramolecular
structures, especially cholic acid (shown in figure 1 . 10). These surfactant properties
are used to promote the absorption ofwater-insoluble compounds.
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R1 R2
Cholic acid OH OH
Deoxycholic acid H OH
Chemodeoxycholic acid OH H
Lithocholic acide H H
Figure 1.9 The chemical structures of selected bile acids. Bile acids have a
rigid planar structure with a hydrophobic face and a hydrophilic face,
making them excel lent detergents.
Figure 1.10 The structure of cholic acid.89 Cholic acid is an amphiphilic
molecule. It may be also important in disrupting membranes and activating
an inflammatory response by macrophages.
CH
OH
Hydrophobic
24
OH
Hyd ro ph iii c
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Cholic acid is one of the most abundant bile acids in humans, being present for
the most part conjugated in amide linkage with the amino acids glycine or taurine,
yielding glycocholate and taurocholate, respectively. Chemically, cholic acid is a
cholan-24-oic (cholanic) acid (the terminal C24 of cholane becoming a —COOH
group); biologically, cholic acid is derived from cholesterol ta cholestane
derivative) and displays oxidation (OH groups) and orientation at positions 3, 7 and
12. Cholic acid is soluble in acetic acid and most organic solvents, and sparingly
soluble in water. Quaternary ammonium bile salts were synthesized by some
researchers, with very i nteresti ng pharmacological applications (such as antiviral
and antifungal agents).9° furthermore, cationic bile salt conjugates with polyamines
were shown to dramatically increase the cellular uptake ofDNA.9’
Cholesterol-modified short interfering RNA also known as “siRNA” (the
siRNA interferes with the expression of a specific gene in the RNA interference
pathway) showed increased stability and gene silencing activity in the
investigation.92 As disease processes also depend on the activity of multiple genes,
it is expected that in some situations tuming off the activity of a gene with a siRNA
couÏd produce a therapeutic benefit. Because bile acids derivatives of cholesterol, it
may also increase the tissue bioavailability in a variety of organs, just like
cholesterol. The modified bile acids may also enhance the cellular penetration ofthe
DNA or siRNA complex and overcome some of the problems of the transfection
and toxicity in gene delivery systems.
Polymers made from the bile acids are extremely adaptable and present many
properties which could be applied to both internal and extemal wrapping of
pharmaceutical products. In certain cases they have been already used for such
applications. Additional functionality can then be incorporated by using
responsive polymers which can be triggered by a change in pH and temperature. ‘
96, 97 Amino derivatives of bile acids obtained by the modification of carboxylic side
chain or replacement of OH groups with amino groups were found useful for
binding inorganic ions and DNA receptors.94’°8
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Some of the polymers based on bile acids are hydrogels which can swell in
water without dissolving. Hydrogels are usually made of hydrophulic polyrners
which are cross-linked via chemical bonds, hydrogen bonding, ionic interactions,
and bydrophobic interactions. The polymers of bile acids can preserve some ofthe
properties of bile acids such as facial amphiphilicity, chirality and capacity to self
assemble. Our group bas developed many bile acid-derived polymers. These
polymers possess good biocompatibility and some of them are biodegradable,
which present a potential for biomedical applications.94
1.6 Design of cationic polymers containing bile acid derivatives
Currently, non-viral vectors show rather lower transfection efficiency
compared to viral vectors. In addition, many of the liposomes and polymers
investigated thus far display considerable toxicity. Therefore, there is a great
interest in improving the biocompatibility ofpolymeric gene vectors.
In the past, our group bas studied polymers containing derivatives of bile
acids, whicb maintain some of the characteristics of bile acids and show interesting
biocompatibility. Up to now, neutral and negatively charged polymers of bile acids
have been studied in our group.94 To our knowledge, this work describes the first
attempt to prepare cationic polymers containing derivatives ofcholic acid.
The hypothesis of this work is that the incorporation of derivatives of bile
acids in cationic polymers will help alleviate certain issues related to their use.
Since bile acids are endogenous compounds, polymers made with such materials
may be more biocompatible compared to the currently used polymers for non-viral
vectors. furthermore, the facial amphiphilicity of bile acids may promote
complexation with DNA as well as transfection. The use of bile acids for preparing
cationic polymers is considered justified given that polymers containing bile acids
are adaptable and versatile.
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In this research, the primary interest is to synthesize positively charged
polymers containing derivatives of bile acids for use as a gene vector. Furthermore,
since ail the charged polymers are sensitive to pH, this aspect will also be explored.
Its copolymer with NIPAM should add the interesting feature of thermo sensitivity.
For this purpose, we plan to modify the carboxylic acid group on cholic acid to
a quaternary amine. The alcohol on position 3 will be modified to a polymerizable
group. Alternatively, the quaternary amine group on these monomers can be Ïeft as
a free primaiy amine, thus confening pH sensitivity to the polymer. Finally, should
solubility become an issue, these monomers could be copolymerized with other
monomers such as NIPAM. The incorporation of NIPAM may also induce thermo
sensitivity in the resulting copolymers, thus allowing for another mechanism for
stimulated release.
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CHAPTER 2
EXPERIMENTAL
2.1 Materials
Cholic acid (CA, 98%), NN-dimethyÏ ethylenediamine (DMEDA, 95%),
N,N-ethylenediamine (EDA, 98%), di-tert-butyl dicarbonate (Boc2O, 97%), and N
isopropylaciylamide (NIPAM, 97%) were purchased from Aldrich and were used
as received without further purification unless specified in the text. 2,2-
Azobis(isobutylonitrile) (AIBN) was purchased from Aldrich and recrystallized
from methanol before use. Methaciyloyl chloride 80% was purchased from Aldrich
and distilled immediately prior to use. Ail organic solvents were purchased from
Aldrich. Methanol, chloroform, tetrahydrofuran (THF, dried with sodium), and
triethylamine (TEA, dried with sodium), N,N-dimethylformamide (DMf, dried
with potassium hydroxide) were dried using a column solvent purification system
unless otherwise specified.
2.2 Synthesis of monomers
2.2.1 [(2 ‘-Dirnethylamino)ethylenej -3cJ-methacrytoyl-7cL,12cL-dihydroxy-5-
cholanoamide 4
(1) Cholic acid methyl ester (2)’
In a 150 mL round-bottom flask equipped with magnetic stirrer and condenser,
70 mL ofmethanol and 14 g of 9$tY0 CA 1(32.8 mmol) were acidified with 0.5 mL
HCI and heated to reflux for 1 h. The solution was allowed to cool to ambient
temperature and the crude crystals of the methyl ester were separated and
recrystallized in methanol. The purified crystals were collected and dried in a
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vacuum oven at 40 oc overnight to yield 12.6 g (9 1%) of compound 2 (white
powder; T11 = 120-121 oc).
‘1-1 NMR (CDC13) 6 shift: 0.69 (s, 3H, C1$-CH3), 0.89 (s, 3H, c19-C113), 0.9$
(U, 3H, C21-C113), 1.0-2.5 (various ring, aliphatic protons), 3.46 (m, 1H, c3-CH),
3.65 (s, 31-1, 0C113), 3.85 (s, 1H, c7-CH), 3.98 (s, 1H, c12-cH).
(2) [(2’ -Dimethylamino)ethylene]-3 cx,7a, I 2a-trihydroxy-5 f3-cholanoamide (3)
In a 25 mL flask equipped with magnetic stiner and condenser, 1 5 mL of 95%
DMEDA and 6 g ofcholic acid methyl ester 2 (14.4 mmol) were heated to reflux
for 14 h. After the reaction, 30 mL of a water and ice mixture were added to the
solution. The resulting mixture was extracted three times with cH3cl (3 x 20 mL).
The combined organic extracts were washed with saturated brine, and then dried
over anhydrous Na2SO4 The solvent was rernoved by rotary evaporation and the
crude product was purified by column chromatography on silica gel with methanol
as eluent (R= 0.12). 4.6 g (66%) ofa colorÏess compound 3 was obtained (T11 =
192-193 oc).
‘H NMR (cDcl3) 6 shift: 0.73 (s, 3H, C 18-Cil3), 0.94 (s, 3H, c19-d113), 1.05
(U, 3H, c21-dH3), 1.0-2.5 (various ring, aliphatic protons), 2.58 (s, 6H, N-(CH3)2),
2.84 (s, 2H, (cH3)2-N-dH2), 3.46(s, 2H, coNH-d112), 3.52(m, 1H, C3-CHOH ),
3.86 (s, 1H, c7-dHoH), 4.01 (s, 1H, c12-cHoH).
(3) [(2’ -Dimethylamino)ethylene]-3a-methacryloyl-7Œ, 1 2a-dihydroxy-5 f3-
cholanoamide (4)
Method 1
In a 150 mL three-necked flask equipped a magnetic stirrer, 0.06 mL of
distilled methacryloyl chloride (0.57 mmol) was dissolved in 3 mL anhydrous THF
was added dropwise under nitrogen to a solution made of 0.19 mL dried
triethylamine (2.6 mmol), 250 mg compound 3 (0.52 mmol), and I 5 mL anhydrous
THF at O °C (ice bath). After the addition of the methacryloyl chloride, the
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temperature was slowly raised to room temperature and the solution left to react for
a further 24 h. Under these conditions no reaction was evident by TLC.
Method 2
In a 150 mL three-neck flask equipped with a magnetic stirrer, 0.06 mL of
distilled methacryloyl chloride (0.57 mmol) was dissolved in 3 mL anhydrous THF
and added to a mixture of 0.16 mL pyridine (2.09 mmol), 250 mg of compound 3
(0.52 mmol), and 15 mL anhydrous THF at O oC (ice bath) under nitrogen purge.
After the addition of methacryloyl chloride, the temperature was slowly raised to
room temperature and mixture was left to react for a further 24 h. Under these
conditions no reaction was evident by TLC
Method 3
In a 50 mL three-neck fiask equipped with a magnetic stilTer, 0.06 mL of
distilled methacryloyl chloride (0.57 mmol) was dissolved in 1 mL anhydrous
DMF and added to a mixture of 0.19 mL triethylamine (2.6 mmol), 250 mg of
compound 3 (0.52 mmol), and 7 mL anhydrous DMF at O °C (ice bath) under
nitrogen purge. After the addition of methacryloyl chloride, the temperature was
slowly raised to room temperature and the mixture was left to react for a further 24
h. Hydroquinone (inhibitor) (0.1 mg) was added, then DMF was removed by rotary
evaporation at 50 °C. A drop ofa NaOH solution (—3.12 mmoi) and 8 mL methanol
were added to the crude prodctct. The mixture was stirred for 1 h, the sait removed
by filtration, and the solvent evaporated. The crude prodtict was purified by colunm
chromatography on silica gel with methanol/THF (v/v = 1: Ï) as eluent (Rf = 0.3).
The yieid of 4 was 25.6 mg (9%) (T01 = 115 °C).
H NMR (CDCI3) shift: 0.73 (s, 3H, C18-CH3), 0.94 (s, 3H, C 19-Cil3), 1.02
(d, 3H, C21-d113), 1.0-2.5 (various ring, aliphatic protons), 1.94 (s, 3H CH2=C-
Cil3), 2.37 (s, 6H, N-(CH3)2), 2.57 (ni, 2H, (CH3)2-N-CH2), 3.4 (iii, 2H, CONH
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Cil2), 3.87 (s, 1H, C7-CHOH), 4.01 (s, 1H, C12-CHOH), 4.62 (ni, 1H, C3-Cil),
5.52 and 6.08 (d, 2H, CH2=C).
2.2.2 [(2 ‘-tert-butyloxycarboxamido)ethylenej -3c-methacryloy1-7, 1 2i-
dihydroxv-51-choIanoamide 7
(1) [(2’ -Amino )ethylene]-3 ci,7a,] 2c-tri hydroxy-5 f3-cholanoam ide (5)2
In a 150 mL flask equipped with a magnetic stirrer and condenser, 50 mL of
98% EDA and 6 g cholic acid methyl ester 2 (14.4 mmol) were heated to reflux for
1 6 h. The mixture was cooled to room temperature and 40 mL of a water and ice
mixture were added and stllTed for a further 5 h. The precipitate was filtered then
washed with water. The crude product was dried in a vacuum oven overnight at
40°C until a constant weight was obtained. 5.5 g (85%) of compound 5 was
obtained (T 21 7 °C).
‘H NMR (MeOD) 3 shift: 0.73 (s, 3H, C 18-Cil3), 0.94 (s, 3H, C 19-Cil3). 1.06
(d, 3H, C21-C113), 1.0-2.5 (varions ring, aliphatic protons), 2.75 (t, 2H, NH-C112),
3.26 (U, 2H, CONH-CH2), 3.47 (iii, 1H, C3-Cil), 3.81 (s, 1H, C7-CHOH), 3.97 (s,
1H, C12-CHOH).
(2) [(2’ -tert-butyloxycarboxamido )ethylene]-3 cL,7a, I 2a-trihydroxy-5 f3
cholanoamide (6)
In a 250 mL flask equipped with a magnetic stirrer and condenser, a solution
of 97% Boc2O, 20.7 g (73.5 mmol) in 30 mL MeOH was added dropwise into 70
mL of MeOH containing 3 1.5 g (70 mmol) of compound 5. The reaction was left at
room temperature for 5 h after the addition of Boc2O. The solvent was removed by
evaporation under reduced pressure and then ethyl acetate (120 mL) was added to
dissolve the residue. The organic phase vas washed with saturated brine twice,
dried with NaSO4 and then concentrated under reduced pressure. The crude
product was purified by column chromatography on silica gel with methanol and
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ethyl acetate (v/v 1:1) as eluent (R1-= 0.21). Product was dried in a vacuum oven
overnight to yield 34.7 g (90%) ofcompound 6 (T111 = 112-113 °C).
H NMR (CDCY3) 6 shift: 0.7 (s, 3H, C18-Cil3), 0.91 (s, 3H, C19-CH3), 1.02
(d, 3H, C21-CH3), 1.0-2.5 (various ring, aliphatic protons), 1.46 (s, 9H, COQ
C(C113)3), 3.27 (s, 2H, CONH-CH2), 3.37 (s, 2H, C112-NH-Boc), 3.4$(m, 1H, C3-
CII), 3.87 (s, 1H, C7-CHOH), 3.99 (s, 1H, C12-CHOH).
(3) [(2’ -tert-butyloxycarboxamido)ethylene]-3a-methacryloyl-7a, 1 2a-dihydroxy-
5f3-cholanoamide (7)2
To a 150 mL three-neck fiask equipped with a magnetic stilTer, 0.67 mL of
distilled methacryloyl chloride (6 mmoÏ) dissolved in 10 mL dried THF was added
dropwise to a solution containing 2.8 g of compound 4 (5.0 1 mmol), 7.3 mL of
TEA (10 mmol), and 45 ml of anhydrous THF at O °C under a nitrogen purge.
After the addition of methacryloyl chloride, the temperature was slowly raised to
room temperature and the mixture was left to react for 24 h. The reaction mixture
was filtered, and the solvent removed by rotary evaporation. Chloroform was
added to dissolve the residue and was then washed twice with saturated brine. The
mixture was dried with Na2SO4, and then the solvent was removed under vacuum.
The crude product was purified by column chromatography on silica gel with
methanol and ethyl acetate (v/v = 1:10) as eluent (Rr= 0.3). 1.8 g (57%) of 7 was
obtained (T11 = 105-106°C).
Elemental analysis: CaIc.: N: 4.53%, C: 67.96%, H: 9.39%; FoLLnd: N: 4.28%,
C: 67.18% H: 9.66%.
H NMR (CDC13) 6 shift: 0.73 (s, 3H, C18-CH3), 0.94 (s, 3H, C 19-Cil3), 1.02
(U, 3H, C21-CH3), 1.0-2.5 (various ring, aliphatic protons),1.46 (s, 9H, COQ
C(CH3)3), 1.94 (s, 3H, CH2=C-CH3), 3.29 (s, 2H, CONH-CH2), 3.36 (s, 2H, Cil2-
NH-Boc), 3.88 (s, 1H, C7-CilOH), 4.07 (s, 1H, C12-CHOH), 4.65 (ni, 1H, C3-
CII), 5.53, 6.09 (d, 2H, C112=C).
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3C NMR (CDC13) shift: 12.7 (1C, C18-CH3), 17.9$ (IC, C19-CH3),
18.76(ÏC, C21-CH3), 28.91 (3C, COO-C(CH3)3), 46.8$ (2C, CONH-CH2), 68.75
(1C, COO-C(CH3)3), 73.64 (1C, C7-CH), 75.20 tiC, C12-CH), 79.89 (1C, C3-
CH), 125.4 tiC, CH7=C), 137.5 (1C, cH7=c), 157.42 tic, NH-CO-O, Boc),
167.97 (ic,NH-CO-cH2), 175.39 tCH2=C-CO-O), 21.5-42.19 (various ring CI-12)
2.3 Syntheses of polyrners
2.3.1 Homopolymers
Ail polymers were synthesized by free radical polymerization in anhydrous
THF using AIBN as initiator. AIBN was purified by recrystallization in
chioroform3 or ethanol4 and dried in a vacuum oven prior to use.
t 1) Poiy[t2 ‘-tert-butyloxycarboxamido)ethylene-3 a-methacryÏoyl-7a, 1 2a-
dihydroxy-5 [3-cholanoamide] tPCAMA-Boc; 8)
The polymerization was calTied out by the use of a previously reported
procedure with some modiflcations.
In a 25 mL flask equipped with a magnetic stiner and condenser, 700 mg
(1. 13 mmol) of monomer 7 and 4.5 1 mg tO.03 mmol) AIBN were introduced and
the system purged with a stream of nitrogen for 30 minutes. 10 mL anhydrous and
degassed THF was then added and the temperature was raised from room
temperature to 70 °c over a period of 2 h. The temperature was maintained at 70 °C
for about 4$ h tuntil the polymerization to complete). After verification that the
reaction was complete by H NMR spectroscopy, the solution was cooled to room
temperature and THF was removed by rotary evaporation. The polymer was
dissolved in a minimal amount of THF and precipitated in petroleum ether. The
volume ratio of THF to petroleum ether was 1:3. The precipitate was collected by
centrifugation of the reaction mixture. The white homopolymer was dried at so °C
for 24 h in a vacuum oven. 0.61 g t87%) of compound 8 was obtained. The
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molecular weight determined by SEC was = 53,700, M11 = 37,900, M/M =
1.42.
(2) Poly[(2 ‘—ammonium chloride—amino)ethylene—3 a—methacryloyl—7a, 1 2a—
dihydroxy-5 -cho1anoamide] (PCAMA-NH3CF; 9)
In a 25 mL flask equipped with a magnetic stilTer and condenser, 250 mg of
compound 8 (0.41 mmol) was dissolved in 5 mL THF. After addition of 0.82 mmol
of 39% hydrochloride acid, the reaction was stined at room temperature overnight.
‘H NMR spectroscopy was used to monitor the disappearance of the tert
butyloxycarbonyl group. THf was partially removed in vacuo and washed with
deionized water. The deprotected and protonated polymer was dried at 50 °C for 24
h in a vacuum oven, yielding 0.23 g (93%) ofcompound 9.
(3) Poly[(2 ‘-aminoethylene)-3 a-methylacryloyl-7a, 1 2a-dihydroxy-5 f3-
cholanoamide] (PCAMA-NH7; 10)
100 mg of compound 9 was dissolved into a small quantity of methanol. The
solution was passed through a column containing (Dowex Z-X8, 0W form), using
methanol as the eluent. The methanol solution was collected and evaporated to
diyness. Compound 10 was further dried at 50 °C for 24 h in a vacuum oven to
give 10 (IOO1Y0 yield).
2.3.2 Copolymers
Ail copolymers were synthesized by free radical polymerization in anhydrous
THF using AIBN as initiator. A series of Boc protected copolymers with different
molar ratios of NIPAM and monomer 7 (namely 3, 6, 10, and 20 mol% of
monomer 7) were prepared. An exampie of a typical procedure for copolymers
which contain 10 moÏ% of monomer 7 is given below.
(1) Poiy NIPAM-co-{(2 ‘-tert-butyioxycarboxamido)ethyiene-3 Œ-rnethacryloyl-7a,
1 2a-dihydroxy-5 3-cholanoamide] } [poly(NIPAM-co-CAMA-Boc); 1 2]
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Copolymer 12 was prepared by combining 0.5 g (0.81 mmol) ofmonomer 7,
0.82 g (7.29 mmoÏ) of NIPAM 11, and 32.2 mg (0.24 mmol) AIBN in a 25 mL
flask equipped with magnetic stiner and condenser. The system was purged with a
stream ofnitrogen gas for 30 minutes. Anhydrous THF (10 mL) was added and the
system was heated from room temperature to 70 °C for 2 h (at a rate of —0.5
°C/min). The temperature was maintained at 70 °C for 24 h. Once the
copolymerization was complete, as verified by f{ NMR spectroscopy, the solution
was cooled to room temperature and THF was removed by evaporation. The
copolymer was dissolved in a small amount of THF and precipitated by the
addition of petroleum ether (volume ratio of THF to petroleum ether 1: 1). The
copolymer 12 precipitate was filtered and dried at so °C for 24 h in a vacuum oven
to give a white solid 1.2 g (88%).
The copolymers poly(NIPAM-co-CAMA-Boc) 12 containing 3, 6 and 20
mol°,4) of monomer 7 were prepared in the same fashion with yields of 0.95 g
(92%), 1.02 g (88%) and 1.49 g (86%), respectively, by adding 0.15, 0.3 and 1 g of
monomer 7 to 0.88, 0.86 and 0.73 g ofNIPAM 11.
Poly(NIPAM-co-CAMA-Boc) (containing 10 mol% ofmonomer 7) ‘H NMR
(CDCh) 5 shift: 0.73 (s, 3H, C18-CH3), 0.94 (s, 3H, C 19-Cil3), 1.02 (d, 3H, C21-
cil3), i .0-2.5 (various ring, aliphatic protons), 1.46 (s, 9H, COO-C(CU3)), 1.94 (s,
3H, CH7=C-CH3), 3.29 (s, 2H, CONH-d112), 3.36 (s, 2H, CH2-NH-Boc), 3.88 (s,
1H, C7-CHOH), 4.0 (s, 1H, c12-CHOH), 4.65 (m, 1H, c3-CH), 5.53, 6.09 (d, 2H,
CH2=C).
(2) Poly NIPAM—co—[(2 ‘-ammonium chloride—amino)ethylene-3 a-methacryloyl
7a, 1 2a-dihydroxy-5 3-cholanoamide] } [po1y(NIPAM-co-CAMA-NH3CF): 13]
In a 25 mL flask equipped with a magnetic stirrer and condenser, 250 mg
(1.53 mmol) of 10% copolymer poly(NIPAM-co-CAMA-Boc) 12 was dissolved in
5 mL TI-IF. 39% hydrochloride acid (3.1 rnmol) was added and the reaction left at
room temperature for 5 h. ‘H NMR was used to monitor the disappearance of the
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tert-butyloxycarbonyl group. The solvent was evaporated and copolymer 13 dried
at 50 °C foi- 24 h in a vacuum oven, to give a beige solid 0.24 g (98%).
The copolymets po1y(NIPAM-co-CAMA-NH3C1) 13 containing 3, 6 and 20
mo1°/ ofmonomer 7 were prepared in the sanie fashion with yields of 0.24 g (96%),
0.24 g (97%) and 0.24 g (95%), respectively, by adding 0.92, 1.84 and 6.2 mL of
39% hydrochioride acid to 250 mg of copolymer 13 containing 3, 6 and 20 mol%
of monomer 7.
To simplify the names and distinguish the copolymers, they are named by
using mol% content of monomer 7. For instance, poly(NIPAM-co-CAMA-Boc)
contained 10 mol% of monomer 7 is named as poly(NIPAM-co-10%CAMA-Boc);
po1y(NIPAM-co-CAMA-NH3C1) contained 3 mol% of monomer 7 is named as
poly(NIPAM-co-3 %cAMANH3c1).
2.4 Methods of physical char acterization
2.4.1 Nuclear magnetic resonance
‘H NMR spectra were recorded on a BrcLker AMX-400 spectrometer operating
400 MHz foi- protons and 100 MHz for carbon-13. The samples were dissolved in
deuterated chloroform or deuterated methanol, as indicated in the text.
2.4.2 Elemental analysis
Elemental analyses of the monomers were donc using an EA 1108 CHN
analyzer by Fisons instruments
2.4.3 Mass spectrometry
The low resolution mass spectrometiy of the monomer was donc on a MS 50
TC TA instrument. The monomer was bombarded by a cluster of high-energy
electrons 50 that some ofthe molecules converted into ions.
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2.4.4 Thermogravimetric Anal sis
The thermogravimetric behaviout of ail polyrners were recorded using a Ri
Res TGA 2950 thermogravimetric analyzer from TA instruments at a heating rate
of 1 5 °C/min to a final temperature of 600 °C and under a flow of nitrogen.
2.4.5 Size exclusion chrornatography
The molecular weight of the polymer samples was determined by size
exclusion chromatography (SEC), using a ‘Vaters 1525 pump, a Waters 717 Plus
autosampler, a Waters 2410 differential refractometer detector, and a column
heater at 35 °C. Three 30 cm Waters colunms (Waters Styragel RR3, HR4 and
I-1R6) with range of molecular weights of 500-i07 were used with THF as the
mobile phase at a flow rate of I mL/min. The polymer samples were dissolved in
the mobiie phase and filtered through a 0.2 tm teflon filter. A volume of 100 tL of
polymer solution was injected for each sample. Polystyrene Shodex SM-105
samples were used as standards to construct a calibration curve. Data collection and
analysis were donc using Waters Breeze software.
2.4.6 Ultraviolet-Visible spectrophotornetry
The cloctd points were measured optically, by the use of a CARY 100 BIO
UV-visible spectrophotometer, coupled to a temperature controller. A quartz
sample ccli with a 10 mm optical path containing —-3 mL of the polymer solution
was used. The polymer concentration xvas maintained at 1 .5 wt/v%, and distilled
water was used as a reference. The pH values (measLlred with a pH meter) were
adjusted by the addition ofNaOR solutions and ranged from 2 to 7 (see 2.5.1 pH
sensitivity of the homopolymer). The polymer solutions were heated from 25 to 50
OC at a rate of I °C/min. The absorption was measured at a wavelength of 500 nm.
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2.4.7 Fourier transform infrared spectroscopy
Ail the homopolymers were characterized on the Bomem (MB-series)
Hartmann & Braun FTIR spectrometer. Ail the samples were ground and pressed
with dry KBr to form thin transparent discs.
2.4.8 pH meter
pH was measured using a pH meter (VWR scientific model 2000) equipped
with a Ag/AgC1 pH, Gel and triode electrodes probe.
2.5 Characterization of pH or thermo-pil sensitivities
2.5.1 p11 sensitivity of the homopolymer
PCAMA-NH3Ci 9 was dissolved in methanol at a concentration of 1.5
wt/v%. NaOH solutions of varying concentrations (namely, I M, 200 mM, 50 mM
and 10 mM) were added in very small quantities to increase the pH in a controlled
manner; pHs of 2.61, 3.1, 3.64, 4.06, 5.2, 5.58, 6.09 and 6.55 (pH was measured
with the pH meter) were obtained. pH values higher than 7.35 could not be
obtained because of the precipitation of the polymer. UV-visible
spectrophotometry was performed in quartz celis with 10 mm optical path lengths.
The pH-sensitivity of PCAMA-NH3CF 9 was evaluated at 25 °C by measuring the
absorbance ofthe homopolymer solutions at a wavelength of 500 nm.
2.5.2 pH sen sitivities of the copolymer
(1) Concentration effect
Aqueous solutions with different concentrations of copolymer 13 were
prepared (namely 0.25, 05, 0.75, 1, 1.25, 1.5, 1.75 and 2 wt/v% by dissolving 2.5, 5,
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7.5, 10, 12.5, 15, 17.5 and 20 mg of 13 in 10 mL of water). The absorption at a
wavelength of 500 nm was measured for ail solutions in a I cm sample ccli,
containing approximately 3 mL of the copolymer solution, against distilled water
(reference). The solutions were heated between 25 and 50 oc at a rate of I °C/min.
(2) SaIt effect
Aqueous solutions with different concentrations of NaCI and containing the
copolymer seties 13 were prepared (Table 2.1). The absorptions at 500 nm ofthese
solutions wet-e measured as described above.
Table 2.1 Concentrations ofNaCl in the copolymers solutions.
Copolymers 13 [NaCI] (wt/v%)
poly(N1PAM-co-3%CAMA-NHCl) 0 1 5 10 15
poly(N1PAM-co-6%CAMA-NH”CÏ) 0 0.5 2 5 10
poly(N1PAM-co-10%CAMA-NH3Cl) 0 2 6 10
(3) Thermo- and pH-sensitivity
180 mg ofpoly(N1PAM-co-CAMA-NH3CF) 13 were dissolved into 12 mL
deionized water (concentration of 1 .5 wt/v%). NaOH aqueous solutions of varying
concentrations (namely, I M, 200 mM, 50 mM and 10 mM) were added in veiy
small quantities to increase the pH. The volume and concentration of the NaOH
solution which was added to the copolymer solution was noted so as to calculate
the final concentration of NaCI. Absorptions at a wavelength of 500 nm of the
copolymer solutions was measured as described above. The pH of the solutions
ranged from approximately 2 to 7 (pH measured by pH meter) and the solutions of
copolymer 13 were heated between 25 and so oc at a rate of I °C/min.
The copolymers poly(NIPAM-co-CAMA-NH3TF) precipitated at certain pH
valcies as follows: poly(NIPAM-co-3%CAMA-NH3tCF) at pH 8.2; poly(NIPAM
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co-6%CAMA-NH3CI) at pH 8.32; po1y(NIPAM-co-1O%CAMA-NH3C1) at pH
8.06.
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CUAPTER 3
RESULTS AND DISCUSSION
3.1 Synthesis ofa monomer bearing a tertiary amine group
3.1.1 Synthetic procedures
The strategy employed to prepare polymers with positive charges involved the
syithesis of monorners possessing a tertiary amine group, which can be quaternized
once polymerized (monomers bearing positive charges are incompatible with most
forms ofpolymerization). A methacrylate derivative ofcholic acid bearing a tertiary
amine group (such as monomer 4) can be synthesized in three steps as illustrated in
Figure 3.1.
In the first step towards the preparation of compound 4, CA I vas esterified to
its methyl ester (2) under conditions previously established in our group. 1.2 This
reaction proceeded well. with a yield of 91%. This was followed by trans
esterification with N,N-dimethyt ethylenediamine (DMEDA) to obtain 3 with a 66%
yield after 24 h. Despite the moderate conversion of this reaction, isolation and
purification by column chromatography are simple. The third step towards
preparing monomer 4 was the acylation of the alcohol group on position 3 of
compound 3 by reaction with methacryloyl chloride in the presence of a tertiary
amine. Unfortunately, the optimization of reaction conditions for the successful
synthesis of monomer 4 was complicated due to the poor solubility and ionization
ofcompound 3 (yield -9%). This vill be further dïscussed in the foltowing section.
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-COOH
CH3OH, HCI
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Figure 3.1 Scheme for the synthesis of polymers containing cholic acid
derivatives bearing quaternary amino groups.
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CA: cholic acid and CAME: cholic acid methyl ester
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3.1.2 NMR spectroscopy and mass spectrometry
The ‘H NMR spectrum ofCA (compound 1) in CD3OD is shown in Figure 3.2.
CD3OD bas two peaks at 3.3 and 4.8 ppm (due to traces ofwater in CD3OD). Most
ofthe peaks lie in a region between I and 2.6 ppm, except for those at 3.78 and 3.89
ppm, which are attributed to the methine protons deshielded by the OH groups at
C7 and C12 positions ofcholic acid. The peak at 3.35 ppm can be attributed to the
CIIOR group at C3. This peak splits into a quintet by the four hydrogen atoms on
the neighboring carbons.
When CA is converted into CAME (compound 2) changes in the ‘H NMR
spectrum are observed (Figure 3.2). The additional sharp singlet at 3.65 ppm is the
signal of methyl ester group at position 24. This is a distinctive feature of the
methyl group of CAME.
The structures of 3 and 4 were conflrmed by ‘H NMR spectroscopy as shown
in figure 3.3. The NMR spectrum of compound 3 confirrns the successful isolation
ofthe inteniiediate. The chemical peaks a, b, e and d at 3.43 (a), 2.84 (b) and 2.6 (e,
d) ppm are attributed respectively to the protons on DMEDA which are attached to
position 24 of cholic acid. Moreover, the peak at 2.6 pprn is due to the dimethyl
groups on the DMEDA. The integrations ofthese peaks are also consistent.
Figure 3.3 shows the ‘H NMR spectrum of monomer 4. We note the presence
of two peaks at 5.6 and 6. 1 ppm which conflrms the presence of a double bond on
monomer 4. The sharp singlet at 1 .9 ppm is attributed to the methyl group of the
methacrylate. The peak for position 3 shifted from 3.52 to 4.62 ppm because the
hydroxyl group was replaced by an ester. Thus, it is established that the
methacrylate double bond was introduced into the molecular structure. The NMR
integration of monomer 4 is in agreement with its structure. It is concluded from the
experiments that the synthesized monomer 4 bas the expected structure.
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Figure 3.2 ‘H NMR spectra of compound 1 in CD3OD and 2 in CDC13.
These spectra show the appearance of a singlet at 3.65 ppm, characteristic
ofa methyl ester.
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figure 3.3 ‘H NMR spectra of compound 3 in CDC13 and 4 in CDC13.
These spectra cÏearly show the presence of the DMEDA on position 24
of compounds 3 and 4 (peaks a-d) and a methacrylate group on
monomer 4 (peaks H1, H7, f).
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The structure of 4 also was confirmed by mass spectrometry (Figure 3.4). The
mass spectrum of monomer 4 shows a peak at 547.4 amu corresponding to
monomer 4 with the molecular ion +H [546 + 1 = 547]. Another peak at 569.4 amu,
corresponding to monomer 4 with a sodium ion [546 + 23 = 569] is also observed.
4.0e5
547.4
[546+HJ
U)
I :::
1.0e5
569.4
289.9 [546+NaJ
400 600 800 1000
m/z. amu
Figure 3.4 Mass spectrum of monomer 4.
3.1.3 Aspects of the synthesis
The reaction of CAME with EDA served as a reference for the reaction of
CAME with DMEDA2. DMEDA served two purposes in this reaction: reagent and
solvent. The reaction had a yield of 66%. However, the reference reaction with
EDA yields 92%. Comparing these two reactions, production of DMEDA occurs in
much lower yield. The reaction was analyzed by thin layer chromatography (TLC)
afier 5, 16 and 24 h. On the TLC, two clear spots were observed: the starting
material CAME with Rf = 0.92, and the product compound 2 with Rf= 0.12 using
methanol as eluent. Afier 24 h the starting material CAME was present in the same
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proportion as after 16 h. The main difference between these reactions is that the
reaction with DMEDA was conducted in a very concentrated solution and the
incomplete reaction caused a lower yield. However, due to the absence of by
products as well as marked difference in R of the starting material and the product,
the purification by column chromatography was very simple.
As stated in the previous section, the acylation of compound 3 to the
methacrylate 4 was greatly complicated by three factors: solubility, ionization, and
purification.
(1) Solubility
Compound 3 was quite polar and only soluble in certain solvents. Compound 3
was insoluble in dichioromethane and toluene, and only poorly soluble in heated
THF (1O mg/mL). The reaction in THF was attempted, but, due to poor solubility,
no reaction occuned. Solubility in DMF and in dimethylsulfoxide was adequate, but
removal ofthe solvent was difficuit given their high boiling points (153 and 189 °C
at I atm, respectively). Generally, removal of the solvent under vacuum required
that the reaction mixture be heated to a point where polymerization of the excess
methacryloyl chloride (and by-products) and the monomer 4 occurred (5O °C). To
minimize this problem, small amounts of hydroquinone, a free radical
polymerization inhibitor, were added to the reaction mixture.
(2) Ionization
Aside from the poor solubility of 3 in organic media, its acylation was further
complicated by ionization ofthe ternary amino group on either 3 or 4 which caused
immediate precipitation to occur. Typically, acylation with acid chlorides required
the presence of a bulky amine accelerator, which acts as a good leaving group, by
activating the acid chloride as seen in Figure 3.5. The pendant tertiaiy amino group
on 3 or 4 may also act as an accelerator, thus becoming positively charged (by
products I and 2) and further decreasing its solubility in the organic media (Figure
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3.6). In the present case, TEA (pKa = 11.01) or pyridine tPKa =5.21) were added to
the reaction mixture to promote acylation, but no difference was obseiwed.
O R OR
II I II I()
R-C-CI + N—R
R Ï
Figure 3.5 Activation of an acid chloride by a tertiary amine.
Compound 3
Compound4
HN
figure 3.6 Representation of the ionization of the tertiary amino group
on 3 and 4 during the methacrylation. 3 and 4 are pooriy soluble in DMF,
by-products 1 and 2 are insoluble in DMF.
HCI
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e
H
OH
by-product I
HCI
OH
H by-product 2
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(3) Iktrification
Finally, because of the polarity of compounds 3 and 4, isolation by column
chromatography using silica gel was difficuit. Generally, at the end of the
methacrylation reaction, as many as 7 spots were seen on the TLC plate. The
purification by silica gel column chromatography was carried out 3 times.
Impurities with large differences in polarity can be first removed by a preliminary
flash column. Then the pure compound was collected after the second and third
columns. However, those products with similar polarities often had long trails as
shown on the TLC, and consequentiy the isolation of individual compounds was
diffi cuit.
The overali yield for the synthesis of monomer 4 from cholic acid 1 was iow
(< 6%). Insufficient quantities of monomer 4 were obtained for in depth
characterization of its properties (aside from ‘H NMR spectroscopy and mass
spectrometiy) or polymerization. Consequently, cationic polymers containing cholic
acid derivatives were not prepared.
3.2 Synthesis ofa monomer bearing a primary amino group
3.2.1 Synthetic procedures
Polymers with pendant amino groups are expected to be pH sensitive. The
strategy used to prepare such polymers involved the synthesis of a monomer
possessing amino groups protected with tert-butyloxycarbonyl (Boc) groups. The
presence of a Boc-ylated amine on the monomer rather than a free tertiary amine
should greatly simplify synthesis, purification, and polymerization of the resuiting
monomers.
The general scheme used to synthesize monomer 7 in four steps from cholic
acid 1 is shown in figure 3.7. As for the previous section, cholic acid I was easily
esterified to a methyl ester 2 with a 91% yield. Transesterification ofcompound 2
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with EDA (as reactant and solvent) obtained 5 with an 85 % yield. Compound 5
was easily recovered in high purity by filtration. The pendant primary amino group
generated on this molecule was protected using Boc2O to give 6 in 5 h (yield 90%).
The isolation and purification of this compound were straightforward by column
chromatography.
Acylation of compound 6 to give monomer 7 was done with methacryloyl
chloride and TEA in TKF with a yield of 57%, substantially better than the yield for
monomer 4 (9%). But, this moderate yield for monomer 7 was not as high as what
was observed for similar reactions previously in our group (the yield of similar
reactions was around 70%) due to difficulties in purification caused by the similar
polarities ofcompounds 6 and 7. This will be further discussed (sec 3.2.3 aspects of
the synthesis).
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Figure 3.7 Synthesis ofprimaiy amine polymer.
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3.2.2 NMR spectroscopy and mass spectrum
The ‘H NMR spectra of monomer 7 and the intermediate compounds 5 and 6
synthesized from CAME are observed in Figure 3.8 respectively. Also, the ‘3C
NMR spectrum ofmonomer 7 is shown in Figure 3.9.
The trans-esterification on compound 5 can be easily observed by ‘H NMR
spectroscopy (Figure 3.8) by the appearance of two triplets at 2.75 and 3.26 ppm
that correspond to the ethylene group from EDA. Concurrently, the singlet of the
methyl ester at 3.76 ppm disappeared due to the replacement by an amide group.
After adding the Roc group to protect the terminal amino group, the ‘H NMR
specti-um of compound 6 on Figure 3.8 shows a sharp singlet at 1.46 ppm which
integrates for the protons of the tert-butyÏ group. Also peak b was shifted down
field (from 2.75 to 3.37 ppm) because of the influence of the carbonate group
attached the amine group.
In the ‘H NMR spectrum, the presence of singlets at 5.53 (vinyl group), 6.09
(vinyl group), and 1 .94 ppm (methyl group) confirms the presence of a
methacrylate group on position 3 of monomer 7. The location of the methacrylate
group at monomer 7 is confirmed by the shift of the proton on the position from
3.4$ to 4.65 ppm caused by the esterification of the alcohol group. The ‘3C NMR
spectrum of monomer 7 (Figure 3.9) presents two peaks at 125 and 13$ ppm
identifiable as vinyl groups (C3 1 and C32). Three carbonyl groups (C25, C24 and
C30) are observed at and 157, 16$ andl76 ppm, respectively. A remarkable d shift
of the tertiary carbon from the Boc group is shown at 69 ppm. The structure of
monomer 7 is confirmed by both ‘H and ‘3C NMR spectrum.
The detailed values ofthe ‘H NMR chemical shifts ofthe final monorner 4 and
7 and their intermediates (compound 3, 5 and 6) are listed on Table 3.1.
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Figure 3.9 ‘3C NMR spectrum ofrnonomer 7 in CDC13.
Table 3.1 ‘H NMR chemical shifts of final monomers and intermediates.
‘H NMR chemical shifts (ppm)
Proton Intermediates Final monorners
3 5 6 4 7
3-CH
7-CH
12-CH
18CH3
1 9-CI-I3
21-CH3
H2C=C-C113
C=CH2
Note; 3, 4, 6 in
3.52
3.84
4.01
0.73
0.94
1.05
3.47
3.81
3.97
0.73
0.94
1.06
N/A
N/A
3.48
3.81
3.97
0.73
0.94
1.05
CDC13 and 5, 7 in CD3OD
4.62 4.65
3.87 3.88
4.01 4.01
0.73 0.73
0.94 0.94
1.05 1.05
1.94 1.94
5.52 & 6.08 5.53 & 6.09
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The structure of monomer 7 was confirmed by elemental analysis and mass
spectrometry (f igure 3.10). The mass spectrum ofmonomer 7 (figure 3.10) shows
a peak at 619.4 amu corresponding to 7 with the molecular ion +H [618.4 + 1 =
619.4]. The principal peak at 641.4 amu, corresponding to 7 with a sodium ion
[618.4 + 23 = 641.4] is also observed. When the unstable molecular ion
decomposes before it arrives at the ionization chamber, a second peak appears at
563.4 amu [619.4 — 57 + 1 = 563.4] (minus a tert-butyl group). In a similar way,
when one Boc group is lost, a third peak appears at 519.4 amu [619 — 101 + 1
519.4].
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o 619.4
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Figure 3.10 Mass spectrum of monomer 7.
3.2.3 Aspects of the synthesis
During the synthesis of compound 5, EDA reacts with CAME at position 24,
producing amide 5 with a yield of $5%•2 The liquid EDA acts as both reactant and
solvent since CAME is easily solubilized at a temperature close to 60°C. b
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maximizing the yieÏd of 5, ailowing time for precipitation was very important after
the reaction.
In order to protect the primary amine group, Boc group was selected.
Methanol diluted reagent Boc2O was siowiy added dropwise into the system and
C02 was produced simultaneously. By releasing the pressure of C02 in the system,
the speed of the reaction was controlled carefully. 2-Methylpropan-2-ol was also
produced which couid be removed by evaporation. Foilowing up the reaction by
TLC after 2 h, we obtained compound 6 with reasonable purity . Smaii amounts of
by-products could be removed by column chromatography on silica gel. Ail the
steps before arriving to the 11mai monomer 7 were successfui with high yieids.
Although many monomers with structures similar to monomer 7 have been
synthesized by this method with yields around $5%,24 in this reaction the final
monomer 7 had a iower yield (57%). Ail the reported monomers were not as polar
as monomer 7. Becatise of the polarity of monomer 7, it is difficuit to purify by
column chromatography silica gel. There are two aspects to be focused: reaction
controi and purification.
(Ï) Reaction control
Compound 6 can be compietely dissoived in THF upon heating. Cooling the
solution in an ice bath preserved the internai temperature of the reaction flask
around O °C whiie methacryloyl chloride was slowly introduced to the system. This
step can prevent the reaction of hydroxyl groups on positions 7 and 12, thereby
reducing the by-products. It is weIi known that the hydroxyi group on position 3 is
more reactive than the other hydroxyl groups. At a iower temperature, this hydroxyl
group is more reactive towards nucieophiiic substitutions.
The use of fresh methacryioyl chloride was also very important for the
syntheses of the final monomers. Methacryioyi chioride was purchased from
Aldrich. It must be distilied under reduced pressure before use, kept in a refrigerator
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and used within two weeks. Otherwise, the colorless liquid gradually becomes
yellowish and slowly polymerizes.
(2) Purification:
The hydroxyl group on compound 6 was converted to the mcthaciyloyl group,
which should be more soluble with a lower polarity than monomer 7. On the TLC
plate, monomer 7 has Rr = 0.3 with a mixture of methanol and ethyl acetate (v/v =
1 :10) as the eluent. However, compound 6 and monomer 7 had very sirnilar
polarities. They are very doser on the TLC plate which caused problems for their
separation. Column chromatography on silica gel must be carried out more than
twice to obtain pure monomer 7. The first colurnn will remove rnost of the by
products, the rest will separate compound 6 from monomer 7. Moreover, it should
be iioted that Iowering the eluent polarity as rnuch as possible will help in the
separation.
Because of the similar polanties between compound 6 and monomer 7, there
was an unexpected separation difficulty in obtaining monomer 7. Enough monomer
7 was nevertheless synthesized to carry on with the polymerization.
Due to the relatively higher chemical reactivity of the OH group at position 3
of CA and the excess amount of methacryloyl chloride, it is veiy possible to obtain
a product with two methacrylate groups as a by-product of the reaction.’ Several
spots with slightly higher Rf than compound 7 (observed by TLC after the reaction)
indicated that the other alcohol groups on 6 may have participated in the
methacrytation reaction. This is a further explanation for the lower than expected
yield for monomer 7! The yield depended on the ratio of methacryloyl chloride and
CA. The NMR integration of monomer 7 indicated a ratio of cholate to
methacrylate of 1: 1. Thus, it is established that only one methacrylate double bond
was introduced into the molecular structure of the compound. Monomer 7 was pure
enough to carry out the polymerization reaction.
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3.3 Preparation of the polymers
3.3.1 pH-sensitive polymer
The synthetic route for PCAMA-NH3CF 9 is illustrated in Figure 3.7. Free
radical polymerization of monomer 7 to PCAMA-Boc 8 was achieved with AIBN
(3 mol%) as the initiator. In order to obtain high molecular weight for the polymer,
the temperature of the reaction was raised gradually from room temperature to 70
°C and maintained at this temperature for 48 h. The reaction was considered
complete when ‘H NMR spectra taken ofaliquots ofthe reaction mixture no longer
displayed protons characteristic of the unreacted double bond on the methacrylate.
Polymer PCAMA-Boc 8 was then precipitated from THF by the addition of
petroleum ether followed by filtration (yield 87%).
The ability to carry out a thermodynamically feasible polymerization depends
on whether the process proceeds at a reasonable rate under a proposed set of
reaction conditions. In this polymerization, a slow heating rate (room temperature to
70 oc takes place during 2 h) and efficient temperature in long reaction time (70 oc
for 48h) were required.
To determine the effect oftemperature on the molecular weight ofthe polymer
produced in a free radical polymerization, two factors have to be considered: y, the
kinetic chain Iength and X, , the number-average degree of polymerization. For
polymerization initiated by the thermal homolysis of an initiator, y can be expressed
by
k [M]
p (1)
2(Jk,1k, [f])’’2
where [M] is the concentration of the monorner, [J] is the concentration of the
initiator, fis the initiator efficiency, k,,, k,, and k, are the rate constants for initiation,
propagation and termination, respectively. If the propagation radicals are terminated
by coupling oftwo chains, the number-average degree ofpo1ymerizationX can be
expressed by
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X,, — 2v (2)
and if the chains are terminated by disproportionation, X,, can be expressed by
(3)
In both cases
k[MÏ (4)
(jkdk/[fl)’2
This equation describes the number-average degree of polymerization X,, to be
inversely dependent on the sqctare root of the initiator concentration. Increasing
initiator concentration leads to short polymer chains and lower degree of
polymerization. Moreover, initiator concentration at the beginning increases when
the temperature is high. Therefore, graduai ly increasing the temperature lowers the
initiator concentration which decreases radical formation and consequently may
yield polymers of higher molecular weight.
The quantitative effect of temperature is complex since the rate and degree of
polymerization depend on a combination of the three rate constants (kd, k and k,).
Each ofthese constants can be expressed by AiThenius-type relationship5
k Ae_E I?T or Ink = In A
— (5)
RT
k is the rate constant, A is the collision frequency factor, E is the Arrhenius
activation energy, R is the rate of polymerization, and T is the temperature. Some
studies have evaluated the values of EJ) (activation energy for propagation) and A,,,
(frequency factor for propagation) . There are remarkable differences between the
values A,,, of more or Ïess steric hindered monomers. The more hindered monomers
(e.g., methyl methacrylate) have much lower A,,, values than the less hindered ones.
Long reaction times may be needed for the polymerization with slow kinetics of the
propagation step due to the steric effects ofthe methaciylate derivatives.3
After polymerization, the Boc group was removed by reacting with
hydrochloric acid to yield PCAMA-NH3tCF 9 as an ammonium sait. The reaction
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was done at room temperature ovemight with a yield of 93%. 1H NMR spectra of
aliquots of the reaction mixture were used to follow this reaction and to confirrn the
absence ofresidual Doc groups.
PCAMA-NH3Cl 9 was passed through an ionic exchange resin to give the
polyamine, PCAMA-NH2. The resin was pretreated with sodium hydroxide aqueous
solution to contain exchangeable 0W anions. While the polymers passed through
the resin, the ions 0W were exchanged with C1 and neutral polymer PCAMA-NH2
10 coctld then be collected. Because PCAMA-NH3CI 9 was not soluble in water,
methanol was used as the eluent.
Given that these polymers have potential applications as environmentally
sensitive drug vectors, moiecular weight and polydispersity are important variables
because they affect the range and abruptness of transitions. Because of the
insolubility of polymer PCAMA-NH3”CF 9 in water or THF (except when heated),
(they was not suitable for SEC measurements on our system). The molecular weight
and polydispersity was estimated from the values obtained for the Boc-yiated
polymer PCAMA-Boc $ (no breakdown of the polymer chains was assumed).
PCAMA-Boc $ had a of 5 3,700 (equivalent to about 87 monomer units) and a
poiydispersity index of 1.42 (a value which is typical for free radical
polymerizations). In principle, the molecular weight of this polymer could be
increased by reducing the amount of AIBN used to initiate the polymerization,
though it is known that the polymerization of bulky monomers is difficult. While
PCAMA-NH3CF 9 is soluble in methanol, DMF and THf (heated), PCAMA-NH2
10 is insoluble in these solvents. After conversions of the ammonium sait group on
PCAMA-NH3C1 9 to an amine group, the resulting polymer PCAMA-NH2 10 was
insoluble in ail solvent tested. Ail the physicai properties were sttidied in methanol.
3.3.2 Thermo and pH-sensitive copolymers
The copolymerization of monomer 7 with NIPAM followed the sanie
procedure as the previously described pH-sensitive polymers. The synthetic route
for poly(NIPAM-co-CAMA-NH3tCÏ) 13 is illustrated in Figure 3.11.
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The copolymers had different solubilities. The NIPAM polymer has a random
coi! conformation leading to enhanced dissolution in water. Ail the Boc-ylated and
hydrolyzed copolymers were soluble in methanol, but became difficuit to solubilize
or insoluble in THF. Poly(NIPAM-.co-CAMA-Boc) 12 could only be dissolved in
THF under heating and poly(NIPAM-co-CAMA-NH3C1) 13 copolymers were
insoluble in THF. When the content of monomer 7 increased, the soÏubility of
poly(NIPAM-co-CAMA-NH3tCF) 13 in H20 decreased. These copolymers were
soluble in aqueous media up to 10 mol% monomer 7 in poly(NIPAM-co-CAMA
N H3C 1) 13, after which the copolymer (poly(NIPAM-co-20%CAMA-NH3CF))
became insoluble. Because of the aforementioned problem of solubility only
poly(NIPAM-co-CAMA-NH3”CF)s 13 containing 3, 6 and 10 mol% of monomer 7
were analyzed in water for their physical properties.
The molecular weights of the copolymers were measured by SEC in THf and
are reported in Table 3.2. Like die homopolymer, only poly(NIPAM-co-CAMA
Boc) 12 was soluble in the eluent THF. The molecular weight was measured for die
poly(NIPAM-co-CAMA-Boc) copolymers.
Table 3.2 The molecular weight of poly(NIPAM-co-CAMA-Boc)s.
Ratio ofmonomer 7 in copolymer M M11 M/M1 Yield ¾
poly(NIPAM-co-3%CAMA-Boc) 40,300 27,300 1.48 92
poly(NIPAM-co-6%CAMA-Boc) 37,200 23,700 1.57 $8
poly(NIPAM-co- 1 0%CAMA-Boc) 35, 100 21,200 1.65 88
poly(NIPAM-co-20%CAMA-Boc) 38,800 22,800 1.70 86
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3.4 Characterization of pH-sensitive polymers
3.4.1 NMR spectroscopy
NMR bas been used for checking reaction completion and for confirming the
structures of the homopolymers. As shown in figure 3.12, the NMR spectrum of
PCAMA-Boc 8 shows the reduction of double bonds on the monomer 7 at 5.53 and
6.09 ppm to tindetectaNe levels indicating that the polymerization was complete.
The remaining chemical shifts remained the same except for the broadened peaks.
The NMR spectrum of PCAMA-NH3CF 9 is shown in figure 3.12. After
deprotection, the peak of tert-butyl group at 1.46 ppm disappeared. The peak b
(CH2-NH-Boc) shifted from 3.36 to 3.52 ppm because the Boc group was replaced
by ammonium chloride group.
The NMR spectra of the homopolymers conflrmed that reactions of
polymerization and deprotection were successfully completed.
PCAMA-Boc 8
PCAMA-NH3Ct 9
crr1l{ r(rr I I 1111(111 [[rIT
6 5 4
rrr,rrrr11 r r r r r r i r r I I J
3 2
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Figure 3.12 ‘H NMR spectra of PCAMA-Boc $ and PCAMA-NH3C1 9
in CDOD.
Boc
a
19
18
21
19
65
was done at room temperature ovemiglit with a yield of 93%. H NMR spectra of
ahquots of the reaction mixture were used to follov this reaction and to confirm the
absence ofresidual Roc groups.
PCAMA-NH3TI 9 was passed through an ionic exchange resin to give the
polyamine. PCAIVIA-NH2. The resin vas pretreated with sodium hydroxide aqueous
so]tition to contain exchangeable 0W anions. While the polymers passed through
the resin, the ions 0W were exchanged with CF and neutral polymer PCAMA-NH2
10 could then be coÏlected. Recause PCAMA-NH3”CF 9 was not soluble in water,
methanol was used as the eluent.
Given that these polymers have potential applications as environrnentally
sensitive drug vectors, molecular tveight and polydispersity are important variables
because they affect the range and abruptness of transitions. Recause of the
insolubility ofpolymer PCAMA-NH3CF 9 in water or THF (except when heated),
(they vas not suitable for SEC measurements on our system). The molecular weight
and polydispersity vas estimated from the values obtained for the Boc-ylated
polymer PCAMA-Boc $ (no breakdown of the polymer chains vas assumed).
PCAMA-Boc $ had a of 53,700 (equivalent to about 87 monomer units) and a
polydispersity index of 1.42 (a value which is typical for free radical
polymerizations). In principle, the molecular weight of this polymer could be
increased by reducing the amount of AIBN used to initiate the polymerization,
though it is known that the polymerization of bulky monomers is difficuit. While
PCAMA-NH3”CF 9 is soluble in methanol, DMF and THf (heated), PCAMA-NH2
10 is insoluble in these solvents. After conversions of the ammoniLtm sait group on
PCAMA-NHtCl 9 to an amine group, the resulting polymer PCAMA-NH2 10 was
insoluble in all solvent tested. AlI the physical properties were studied in methanol.
3.3.2 Thermo and pH-sensitive copolymers
The copolymerization of monomer 7 with NIPAM followed the same
procedure as the previously described pH-sensitive polymers. The synthetic route
for poly(N1PAM-co-CAMA-NH3CF) 13 is illustrated in figure 3.11.
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3.4.2 Fourier transform infrared spectroscopy
The FTIR spectra for homopolymers are shown in figure 3.13. No peak was
observed at 1633 cm’ (stretching of alkene double bonds) confirming the absence
of double bonds in the polymers. The broad bands, ranging from 3600 to 3000cm’,
are due to the characteristic OH bond and hydrogen bond.6 The two peaks at 2930
and 2865 cnï’ were attributed to the C-H, asymmetric and symmetric stretching
vibrations. The stretching of the C=O group is visible around 1712 cm1, and the
vibration ofthe tert-butyl group is at 1375 cnï1. The peaks from 500 to 1500 cm’
region are quite similar for PCAMA-NK3”C1 9 and PCAMA-NH2 10. The FTIR
absorption peaks are listed in Table 3.3.
Wavenumber (cm1)
Figure 3.13 fTIR spectra ofPCAMA-Boc 8, PCAMA-NH3C1 9 and
PCAMA-NK7 10
o
I I I I
4000 3000 2000 1000
NH2 n primary amines &
NH in secondary amides
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Table 3.3 fTIR adsorption of selected functional groups and classes of
compounds.
Wavenumber (cm1) Group and class
3700-3200 (s) -OH in alcohols
3300-3280 (s) -NH in secondary amides
2990-2850 (m-s) -CH3, -CH7-, -CH
1720-1700 (vs) C=O esters
1680-1630 (vs) C=O in secondary amides
1650-1580 (m-s) NH2 in primary amines
1565-1475 (vs) NH in secondaiy amides
1400-1370 (m) tert-butyl group
Note: s = strong, vs = very strong, m = medium
Comparing PCAMA-Boc $ and PCAMA-NH3CF 9, there are significant
signals differences. In Figure 3.13, the peak at 1375 cm (tert-butyl group)
disappeared after the hydrolysis, and the intensities of peaks at 1706 (C=O esters)
and 1537 cni’ (NH in secondary amides) reduced, indicating that the Boc group has
been converted into ammonium chloride.
The resulting charged polymer PCAMA-NH3C1 9 was passed through an ion
exchange resin column (pre-treated with sodium hydroxide) to deprotonate the
pendant amino groctps. This was donc in methanol since the polyrners PCAMA
NH3tCF 9 and PCAMA-NH2 10 (charged and uncharged) were insoluble in water.
FTIR spectra were taken before (compound 9) and after (compound 10) the ion
exchange coÏumn. Due to spectral overlap in the 1500-1800 cni’ region (the NH2 in
primary amine and C=O in secondary amides), identification of the peaks was
difficult. No characteristic peaks of the symmetric or asymmetric stretching of
compound 10 were observed.
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3.4.3 Thermogravîmetric analysis
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The thermal stabilities of homopolyrners were established by TGA
measurement. The TGA decomposition curves are shown in Figure 3.14.
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Figure 3.14 Thermogravimetric analysis of homopolymers: PCAMA
Boc $ (— soiid hue), PCAMA-NH3Ci 9 (--- dashes) and PCAMA
NI-I2 10 ( dots). Temperature dependence of(A) weight loss percentage
and (B) derivative of the weight loss percentage. The decomposition of
ail the homopolymers vas comphicated. PCAMA-Boc $ loses 15.7 wt%
around 200°C because ofthe ioss ofthe Boc group.
Thermogravimetric analysis of polymers PCAMA-Boc 8, PCAMA-NHJCF 9
and PCAMA-NH 10 reveaied that decomposition occured between 300 and 400 oc.
except for PCAMA-Boc 8, which lost its Boc group at 200 oc (Figure 3.15). This
Temperature (°C)
6$
figure 3.15 Thermogravimetric analysis of PCAMA-Boc 8.
Temperature dependence of (A) derivative of the weight loss percentage
and (B) derived weight loss percentage.
was confirmed by the similarity between the expected (16.3 wt%) and observed
(1 5.7 wt%) weight loss (the molecutar weight of the monomer 7 is 61 $ g/mol while
the molecular weight of the Boc group is 101 g/mol). Thus, the percentage of the
Boc group on monomer 7 by weight was 16.4 wt% [101/618=16.4]) when one
calculates the relative mass of the monomer 7 and Boc group. The decomposition
was a complicated process as shown in Figure 3.14. TGA experirnent indicated that
ail ofthe homopolyrners were not very thermally stable.
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3.4.4 pU-sensitivity
The pH-sensitivity of polymer PCAMA-NH3C1 9 was evaluated by
measul-ing the absorbance of a polymer solution (1.5 wt/v% in methanol) at a
waveÏength of 500 nm. In a general procedure, the pH and the absorbance of the
solution containing the polymer was measured, then the pH was readjusted using
NaOH. This was calTied ont incrementally until the polymer precipitated (pH =
7.35). The pH sensitivity ofpoÏymer PCAMA-NH3Cl 9 is shown in Figure 3.16.
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Figure 3.16 PCAMA-NH3CI 9 transmittance changes at 500 nm as a
function of pH at 25 °C in methanol.
However, these resuits must be interpreted in light ofthe fact that pH values of
non-aqueous solutions cannot be accurately compared to those of an aqueous buffer.
The activity of the hydrogen ion varies, depending on the background medium
because of differences in dielectric constants, solvent acidities, and ion mobilities.8
The pH values obtained can only be used as relative measurements. In other words,
the measurement can be used to compare acid-base qualities of sirnilar solvents, and
to indicate when adjustments in pH are needed. It is essential that soïvent
backgrounds of samples and buffers be as similar as possible. The development of
pH scales for non-aqueous solutions is a formidable task. Some work has been done
u
2 3 4 5 6 7
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on methanol and ethanol mixtures.9 When the pH value increased from 2.61 to 6.55,
the percent transmittance (%T) decreased from $5.4 to 74.3%. It gave a rough idea
that the polymer 9 had pH sensitivity in the organic solvent.
3.5 Characterization of copolymers
3.5.1 NMR spectroscopy
The relative amounts of NIPAM and monomer 7 in poly(NIPAM-co-CAMA
Roc) 12 were measured by H NMR spectroscopy (Figure 3.17). As shown in
Figure 3.17, poly(NIPAM-co-CAMA-Boc) copolymers did not show the presence
ofthe double bonds (monomer 7 at 5.53 and 6.09 ppm, or NIPAM at 5.64 and 6.2$
ppm). This indicates that the copolymerization was complete.
Figure 3.1$ shows the ‘H NMR spectra of ail poly(NIPAM-co-CAMA
NH3Cl) copolymers. After deprotection, the peak of Boc at 1.46 ppm disappeared.
Peak b (C112-NH-Boc) shifted from 3.36 to 3.52 ppm because the Boc group was
replaced by ammonium chloride group. The rest of the spectra remained the same
for poly(NIPAM-co-CAMA-Boc) 12.
One of the important facts that can be extracted from NMR data is the
experimental ratio of the monomer 7 to NIPAM within the copolymer. Four
copolymers were made containing 3, 6, 10 and 20 mol% of monomer 7.
Considering the integrations of monomer 7 and NIPAM, the ratio of these
monomers within the copolymers could be obtained. Two signais which were easily
defined and which did not overlap with other peaks were taken into account to
obtain the ratio of the monomers. These peaks were the methyl peak at position 1 $
of CA and the peak from the proton on the tertiary carbon [NH-Cll-(CH3)2J on
NIPAM. The results are shown in Table 3.4. It seems that the experimental molar
ratios of the monomers are slightly higher than the values in the feed. The NMR
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spectra of the honiopolymers contrm that the polymerization and deprotection were
successfully completed.
Table 3.4 The molar percent ofmonomer 7 in the copolymers.
Monomer 7 in the feed (moÏ%) 3 6 10 20
Monomer 7 in poy(NIPAM-co-CAMA-Boc) 35 75 15.4 22.2
measured by NMR experiment (mol%)
Monomer 7 in po1y(NIPAM-co-CAMA-NH3CL) 2.8 6.1 13.3 18.3
measured by NMR experiment (mol%)
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Figure 3.17 H NMR spectra ofNIPAM in CDCI3 and 3, 6, 10 and 20
moÏ% ofmonomer 7 in poÏy(NIPAM-co-CAMA-Boc) 12 in CD3OD.
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Figure 3.1$ ‘H NMR spectra of 3, 6, 10 and 20 mo% ofmonomer 7
in po1y(NIPAM-co-CAMA-NHCF) 13 in CD3OD.
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3.5.2 Thermogravimetry
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The thermal stabilities of ail the copolyrners were established by TGA
measurements. The decomposition of poly(NIPAM-co-CAMA-Boc) is shown in
Figure 3.19 while that ofpoly(NIPAM-co-CAMA-NH3tCfl is shown in Figure 3.20.
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Figure 3.19 Thermogravimetric analysis of poly(NIPAM-co-CAMA
Boc)s. poly(NIPAM-co-3%CAMA-Boc) (— solid une), poly(NIPAM
co-6%CAMA-Boc) (--- dashes), poly(NIPAM-co- 1 0%CAMA-Boc
(« dots) and poly(NIPAM-co-20%CAMA-Boc) ( -- dash dot).
Temperature dependence of (A) weight loss percentage and (B)
derivative ofthe weight loss percentage.
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Figure 3.20 Thermogravimetric analysis of poiy(NIPAM-co-CAMA
NH3C1)s. poly(NTPAM-co-3%CAMA-NH3CF) (— solid une),
poly(N IPAM-co-6%CAMA-NH3Cl) (--- dashes), poiy(NIPAM-co
Ï 0YoCAMA-NH3CF) ( dots) and poiy(NIPAM-co-20%CAMA-
NH3CF) (-- dash dot). Temperature dependence of (A) derivative of
the weight loss percentage and (B) derived weight ioss percentage.
The comopolymers have large range of decomposition temperatures. Almost
ail the weight changes took place between 300 and 450 °C. The temperature at the
highest derivative weight loss was at 400 °c. The TGA experiments indicate that
poly(NIPAM-co-CAMA-NHcL)s had good thermal stability (Figure. 3.20). It
can be seen from Figures 3.19 and 3.20 that between 300 to 360 oc the amount of
decomposition increased with the ratio of monomer 7 in the copolymers
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(poly(NIPAM-co-CAMA-Boc) and po1y(NIPAM-co-CAMA-NH3CF)). This
indicated that decomposition began on the steroid structure.
Integration ofthe weight loss (Figure 3.19) showed the departure ofthe Boc
group at 200 oc was selected as representative of the quantity of monomer 7 in
polymer 12. This approach was deemed justified given the good accord between the
calculated and measured weight loss (of the Boc group) for the homopolymer 8
(Figure 3.15), indicative that there is no loss of the Boc group during
polymerization. Hydrolysis of the Boc group in acidic conditions was followed by
‘H NMR spectroscopy (figure 3.1$) and verifled by thermogravimetric analysis (no
weight loss associated with the departure ofthe Boc group; Figure 3.20).
The ratio of monomer 7 in the Boc-ylated copolymer can be calcuÏated by
percentage of the weight loss of Boc groups (WB0%). We suppose that, in Ï g of
the sample, there are XNPAM mol of NIPAM and Xiioiiier7 mol of monomer 7
(XIoflomer7 XQAMA CAMA is defined as monomer 7 without Boc group).
W 0/
1 — W % — - I — W
-
—
o) Roc) / ‘ o’( moooocr — Ro 1 0 1 / 6 1 $ (6)XNIpM
— M,)NIPAM) — 113
—
— 1Boc
“
— MO)NIPAM) X XNIPAM 1
— WR % 11 3XNIPAM (7)
-
—
n)CAMÀ) — 5 1 7
\Vhere are the molecular weights ofNIPAM (MW(NIPAI) = 113), monomer 7 without
Boc t AIO(CAMA) = 517 ), Boc (AI)n Boc) = 101) and monomer 7 (M0) rnonorner7) 61$).
Because X07 = XB0c = XCAMA
Xmoooocr 7 %(iiiot%)
aI00000ler7
x 100% ($)
X NI l’A M + nooonicr 7
The calculated resuits are shown in Table 3.5. The ratios ofrnonomer 7 in the
copolymers obtained by TGA were higher than the values in the feed, but in
agreement with the NMR resuits (Table 3.4).
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Table 3.5 Theoretical and experimental ratios ofthe monomer 7, and weight
loss ofBoc groups (WB0%) measured by TGA.
Monomer 7 in die feed (moltYo) 3 6 10 20
Percentage ofweight loss of Boc groups 3.07 4.79 6.58 9.38(WBOC%) measured by TGA (wt%)
Monomer 7 in poly(N IPAM-co-CAMA 4.99 8.91 14.23 27.41Boc measured by TGA (mol%)
3.5.3 pH- and thermo sensitivity
Polymers made with NIPAM are known to be thermo sensitive. Inclusion of
NIPAM as comonomer for compound 12 and 13 was done to increase the
hydrophilicity of the polymers (and thus its solubility in aqueous media), but may
also make the latter thermo sensitive. This section describes the solution behaviour
of poly(NIPAM-co-CAMA-NH3CF) 13 copolymers containing 3, 6 and 10 mol%
ofmonomer 7.
(1) SaIt and concentration effects
In order to accurately interpret the potential pH and thermo sensitivity of the
copolymers, the effects of polymer concentration and sait concentration (factors
which are known to influence pH and thermo sensitivity) were first investigated.
The effect of concentration on the thermo sensitivity of polyrner 13 was
evaluated by measuring the cloud points of various aqueous solutions with
concentrations ranging from 0.25 to 2.0 wt/v%. Assumption is made that the effect
of concentration was the same for ail copoiymers. Resuits are plotted in figure 3.21
and show that above 1.2 wt/v%, the thermo sensitivity became independent of
polymer concentration (over the range examined). Ail subsequent measurements
were made at a polymer concentration of 1 .5 wt/v%.
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Figure 3.21 The correlation of poly(NIPAM-co- 1 0%CAMA-NH3CF)
concentration and cloud point in aqueous solution.
The effect of sait concentration was examined for poiy(NIPAM-co-CAMA
NH3CF) 13 containing 3, 6 and 10 moi% of monomer 7 because, in subsequent
sections, the pi-I was adjusted with NaOH, which can increase the concentration of
saits (Figure 3.22).
—I—H2C—CH ] [
H3CCH3
QH OH
NaOH
13
)H + NaCI +H2Q
Figure 3.22 Sait is generated with the addition ofNaOH to solutions
containing po1y(NIPAM-co-CAMA-NH3Ci).
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The variation of cloud point with sait concentration was linear as can be seen
in Figure 3.23. Linear regression of this data provided a means for colTecting the
cloud point measured at discrete sait concentrations.
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Figure 3.23 Correiation of NaCI concentration with cloud point of
poiy(NIPAM-co-CAMA-NH3CF) (1.5 wt/v% in water). (.)
po1y(NIPAM-co-3%CAMA-NH3CF), (.) poiy(NIPAM-co-6%CAMA-
NH3CF), (i) poly(NIPAM-co- 1 0%CAMA-NH3Cl). The linear
correlation functions of the copolymers obtained as CP = 42.95-
0.72[NaCI], CP = 37-1.04 [NaCi] and CP = 34.86-1.24 [NaC1] for
poly(NIPAM-co-CAMA-NH3tC1) containing 3, 6 and 10 mol% of
monomer 7, respectively.
(2) Thermo and pH-sensitivity
The thermo sensitivity of the copolymers poly(NIPAM-co-CAMA-NH3CF)
13 containing 3, 6, and 10 mol% monomer 7 was evaluated at different pHs up until
the pH at which precipitation occurred (the deprotonated form of the copolymer is
less soluble than the charged form). The pHs at which precipitation occun-ed were
8.2, 8.32, and 8.06 for the copoiymers containing 3, 6 and 10 mol% ofmonorner 7,
respectiveiy. The copolymer containing 20 mol% ofmonomer 7 was insoluble at ail
pHs in water and was therefore omitted from these experirnents. The pHs of the
soiutions being initiaiiy acidic, discrete amounts of NaOH were added to increase
0 5 10 15
NaCI concetration (mM)
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the pH (which was measured using a pH meter). The concentration of sait at each
different pH was caiculated and compiled in Table 3.6.
Table 3.6 The concentration of NaC1 under different pH foi- ail the
poly(NIPAM-co-CAMA-NH3CF).
poly(NIPAM-co- poly(NIPAM-co- poly(NIPAM-co
3%CAMA-NH3C1) 6%CAMA-NH3tCF) 1 0%CAMA-NH3CL)
pH [NaC1] pH [NaC1] pH [NaCl]
(1 0 mM) (i 0 mM) (1 0 mM)
1.87 0 1.93 0 2.14 0
2.94 3.3 3.12 4.1 3.10 2.5
3.92 5.5 4.22 6.1 4.51 3.5
4.81 6.4 5.44 6.5 5.33 3.8
5.84 6.5 6.64 6.6 6.49 4.0
7.04 6.9 7.74 7.8 7.41 4.6
7.83 7.2 - - -
From this table, it can be seen that even at high pHs, the concentration of salt
was insufficient to affect the cloud point of the solutions. This parameter can
therefore be negiected.
Figure 3.24 shows the pH dependence of the cloud point of ah three
copolymers. Generally, the cloud point decreased as the pi-1 increased. This can be
attributed to the iower soiubility of the polyrners with increasing pH (less
protonated amine groups). However, over the entire pH range examined, the change
was reiativeiy small: about 25, 1, and 6 oc for the poly(NIPAM-co-CAMA
NH3Cfls 13 containing 3, 6, and 10 mol% of monomer 7, respectively. The lower
vaiues observed with increasing monomer 7 content can potentially be attributed to
a lower pK ofmonomer 7. This would be consistent with the lower solubihity ofthe
copolymer at iower pHs.
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Figure 3.24 Coiielation of pH value and cloud point of poly(NIPAM
co-CAMA- NH3C1) (1.5 wt/v% in water). (.) poly(NIPAM-co
3 %CAMA-NH3tCF), (.) po1y(NIPAM-co-6%CAMA-NH3C1), (À)
poly(NIPAM-co- 1 O%CAMA-NH3tC1).
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CHAPTER 4
CONCLUSIONS
4.1 Synthesis
The syntheses of the monomers were not trivial because of the charges
desired on these compounds. The monomers were only soluble in polar solvents
which made the synthetic approaches and separations very difficuit.
Although a small amount of the monomer 4 was made and its structure
confirmed, the synthesis of a polymer with permanent positive charges met
serions challenges. The structure of monomer 4 may have to be reconsidered in
order to facilitate the purification of the products. The monomer could be
designed to have a less polar structure (such as adding aikyl spacer on position
24). An alternative synthetic strategy is shown in Figure 4. 1. In this case, a
bromo alcohol on position 24 would reduce the polarity of the monomer relative
to the monomers containing an amine group. This bromo alcohol can be
transformed into a quatemized amine after polymerization. This synthetic strategy
may help solve the central problems sunounding solubility, ionization and
purification.
We have overcome the synthetic difficulties of monomer 7. In addition, the
cationic polymer and copolymers have been successfully prepared. Poor solubility
of monomer 7 lcd to the use of many polar solvents since the choice of the right
solvent was very important for these experiments. The solubility of such polymers
in their present form may also limit their uses.
The challenges of this project involved a good understanding of the
solubility, ionization and purification of the compounds. It is imperative that these
challenges be taken care of before initiating further experiments.
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Figure 4.1 Alternative synthetic strategy ofa cationic polymer
containing cholic acid.
4.2 Physical properties ofthe polymers
Two classes of polymers were synthesized: a primary amine cationic
homopolymer and thermo sensitive cationic copolymers.
The cationic homopolymer 9 bearing primaiy amines was not soluble in
water but was soluble in organic solvents such as methanol. The pH-sensitivity of
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this polymer was clearty observed by cloud point experirnents. The polyrner,
although expected to be a hydrogel, did not show swelling characteristics in water.
A more hydrophilic polymer couid be made by copolymerization with a
hydrophilic comonomer to obtain interesting materials for bio-related applications.
In order to improve the solubiiity of polymers containing monomer 7 and to
also confer thermo sensitivity to these polymers, NIPAM was used as comonomer.
These copolymers were found to be pH- as well as thenrio sensitive and were
soluble up to 10 mol% of monomer 7. Copolymer concentration and sait
concentration were also shown to affect the transition temperatures of a selected
copolymer. The cloud point was foctnd to decrease with increasing pH of the
cationic copolymers. The ratio of monomer 7 in the copolymer increased the
cloud point as weÏl. Over the entire pH range examined, the change in cloud point
was relatively small (about 2.5 °C, i oc and 6 °C for polymers containing 3, 6, and
10 mol% of monomer 7, respectively). The copolymers exhibited the general
properties expected, which can be further developed with structure modification,
cross—linking, etc.
Although the solubility and the nanow range of the thermo— and pH—
sensitivities of polymers may limit their applications, future work may help to
overcome some ofthe problems encountered.
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